Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Translation Factors WP107,2.3471109811163512e-05,3.34279297437374,35.63330485929306,"['EIF4A2', 'EIF4A1', 'EIF4EBP1', 'EIF4EBP2', 'EIF4B', 'EIF5B', 'EIF2B4', 'EIF2B2', 'EIF1AX', 'EIF2AK1', 'EIF2AK2', 'EIF2S2', 'EEF2', 'EIF2S1', 'EIF1', 'EEF1A1', 'EIF5', 'EIF2S3', 'EIF6', 'EIF3J', 'ETF1', 'EIF3F', 'EIF3D', 'EIF4G3', 'EIF3A', 'EIF4G1']",0.013683657019908327,0,0,26
2,Proteasome Degradation WP183,8.655440562621205e-05,2.8923387096774196,27.057069028480655,"['RPN2', 'PSMD13', 'PSMA7', 'UCHL1', 'PSMD7', 'PSMB5', 'PSMD4', 'PSMB2', 'UBB', 'PSMB3', 'PSMD2', 'UBC', 'UBE2B', 'HLA-C', 'HLA-A', 'HLA-F', 'PSMB8', 'PSMA3', 'PSMC5', 'PSMA4', 'PSMA1', 'PSMC3', 'PSMA2', 'PSME3', 'PSMC1', 'PSME1', 'PSME2']",0.01865186880042253,0,0,27
3,Ciliary landscape WP4352,9.597874168313478e-05,1.787111400417499,16.533253515481416,"['MCM9', 'MYL6B', 'SMC4', 'HSPB11', 'RPGR', 'EFTUD2', 'PSMD7', 'APMAP', 'ARHGDIA', 'BBS9', 'TMED1', 'RAC1', 'IFT57', 'BBS4', 'RAB2A', 'ZYG11B', 'EIF5B', 'NUDC', 'DYNLT1', 'EIPR1', 'DYNLL1', 'DYNLL2', 'AFG3L2', 'MYL6', 'IFT43', 'MSH2', 'TBC1D4', 'TIPRL', 'CD2BP2', 'EXOC3', 'MCM4', 'MCM6', 'EXOC2', 'PAFAH1B1', 'DDX5', 'ECHS1', 'RALB', 'PSMD13', 'VPS4A', 'COPS7B', 'EHBP1', 'EXOSC7', 'PGRMC2', 'RMND5A', 'EXOSC9', 'TCTEX1D2', 'SNRPB2', 'DCAF11', 'NDUFA9', 'DYNC1H1', 'NDUFA5', 'LCA5', 'NFKB1', 'AIMP1', 'COPS4', 'IFT20', 'MKLN1', 'COPS3', 'COPS6', 'IFT22', 'GID4', 'RAB14', 'MFAP1', 'WNK1', 'CNOT1', 'VAPB', 'GID8', 'CALM1', 'COPS8', 'CALM2', 'CNOT9', 'CLUAP1']",0.01865186880042253,0,0,72
4,Pyrimidine metabolism WP4022,0.0009796733134136142,2.165149691590191,15.000787978287233,"['DTYMK', 'POLD4', 'ZNRD1', 'POLR2A', 'POLR2C', 'POLR2D', 'TWISTNB', 'POLD2', 'POLR2E', 'TK2', 'POLR2G', 'DUT', 'RRM1', 'POLR3GL', 'CTPS2', 'CTPS1', 'NME4', 'DHODH', 'POLE4', 'UCK2', 'POLR3A', 'RRM2B', 'NME7', 'POLR3C', 'POLR3D', 'POLR1C', 'POLR1D', 'POLR1E', 'CMPK2', 'POLR3H', 'UMPS']",0.14278738543003427,0,0,31
5,Photodynamic therapy-induced unfolded protein response WP3613,0.001290672618503803,3.789208783184687,25.208059229494292,"['WARS', 'HSPA5', 'UBE2E1', 'PDIA6', 'HSP90B1', 'BBC3', 'NARS', 'ERN1', 'DNAJB11', 'DNAJB9', 'TRIB3', 'EIF2A', 'ATF4']",0.15049242731754342,0,0,13
6,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.002091688010881604,4.5780616631863404,28.245651043293844,"['EIF5', 'EIF2S3', 'EIF1AX', 'EIF3J', 'EIF3F', 'EIF2S2', 'EIF2S1', 'EIF3D', 'EIF3A', 'EIF1']",0.20324235172399588,0,0,10
7,Oxidative phosphorylation WP623,0.01025981181487024,2.0690038850615213,9.475046287688222,"['NDUFA9', 'NDUFA8', 'NDUFB8', 'ATP5PD', 'ATP6AP1', 'NDUFB6', 'NDUFA5', 'ATP5PB', 'NDUFB4', 'ATP6AP2', 'ATP5MC2', 'NDUFC2', 'NDUFB1', 'ATP5F1A', 'NDUFAB1', 'NDUFS3', 'NDUFS1', 'NDUFV3', 'NDUFV1', 'ATP5MG']",0.8544957554384786,0,0,20
8,Base Excision Repair WP4752,0.014444190565157033,2.4505247882285444,10.384008077267206,"['MBD4', 'FEN1', 'PCNA', 'PARP1', 'MPG', 'APEX2', 'LIG3', 'POLE4', 'POLD4', 'NTHL1', 'APEX1', 'POLD2', 'MUTYH']",0.9561414526029719,0,0,13
9,Intraflagellar transport proteins binding to dynein WP4532,0.014760331172258574,2.5633495841697735,10.806599995881275,"['DYNC2LI1', 'DYNC2H1', 'DYNC1H1', 'IFT22', 'DYNC1LI2', 'IFT43', 'DYNLT1', 'TCTEX1D2', 'WDR19', 'DYNLL1', 'DYNLL2', 'HSPB11']",0.9561414526029719,0,0,12
10,Mitochondrial complex I assembly model OXPHOS system WP4324,0.01753076281893335,1.9649888765294772,7.946018218502827,"['NDUFA8', 'NDUFB8', 'TIMMDC1', 'DMAC1', 'NDUFB6', 'NDUFA5', 'NDUFA12', 'NDUFB4', 'ACAD9', 'NDUFC2', 'NDUFB1', 'TMEM186', 'FOXRED1', 'NDUFAB1', 'NDUFS3', 'NDUFS1', 'TMEM126B', 'NDUFV3', 'NDUFV1']",0.9995105235655231,0,0,19
11,Immune response to tuberculosis WP4197,0.02115588706417375,2.8825787965616048,11.114754163779708,"['STAT1', 'IFNGR2', 'TAP1', 'IFIT1', 'PSMB8', 'IFIT3', 'PTPN2', 'IRF9', 'IFNAR1']",0.9995105235655231,0,0,9
12,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.02221236423447447,5.335336767792406,20.312193675173702,"['UBE2N', 'UBE2V1', 'SQSTM1', 'PRKCZ', 'NFKB1']",0.9995105235655231,0,0,5
13,mRNA Processing WP411,0.025807714449449654,1.4928363487229137,5.459424674255528,"['SF3B2', 'TMED10', 'SF3B3', 'DHX8', 'RNMT', 'DDX1', 'SRP54', 'CSTF2T', 'HNRNPR', 'YBX1', 'EFTUD2', 'POLR2A', 'SNRPD1', 'SNRPB2', 'SNRPD3', 'TXNL4A', 'HNRNPA1', 'SF3B1', 'SF3A1', 'PRMT2', 'NCBP2', 'PRMT1', 'CPSF3', 'SUPT5H', 'CLK3', 'LSM2', 'PRPF4', 'HNRNPM', 'PRPF6', 'HNRNPK', 'PHF5A', 'SNRPG', 'CD2BP2', 'SNRPA1', 'HNRNPH2', 'SNRPF', 'HNRNPC', 'DNAJC8', 'RBMX', 'SNRPB']",0.9995105235655231,0,0,40
14,RAS and bradykinin pathways in COVID-19 WP4969,0.027299494846550913,3.8418551388491267,13.834086535601594,"['SERPING1', 'NOS1', 'KLKB1', 'PRKG1', 'NFKB1', 'RHOA']",0.9995105235655231,0,0,6
15,Fragile X Syndrome  WP4549,0.02898130009401086,1.5028738784195863,5.321833425743515,"['CYFIP2', 'EIF4A1', 'CLTC', 'ITPR1', 'CLTA', 'AKAP5', 'SLC6A1', 'MECP2', 'GRIP1', 'PPP3CA', 'GRM5', 'DAG1', 'AP2S1', 'EIF4EBP2', 'PRKACA', 'NTRK2', 'DUSP3', 'SLC16A1', 'KCND2', 'GAB1', 'PPP2R5B', 'BRAF', 'PTPN11', 'AP2B1', 'EEF1A1', 'ALDH3A2', 'ARHGAP32', 'ARC', 'ALDH5A1', 'PRKAR1A', 'NF1', 'GRB2', 'PLCB1', 'PTPN5', 'TELO2', 'EIF4G1', 'HCN1']",0.9995105235655231,0,0,37
16,Pilocytic astrocytoma WP2253,0.031701035500269203,6.401144492131617,22.092948078189522,"['NF1', 'BRAF', 'PTPN11', 'GRB2']",0.9995105235655231,0,0,4
17,Myometrial relaxation and contraction pathways WP289,0.03576676297703873,1.4550947708025272,4.846536864321882,"['YWHAE', 'RYR2', 'RGS17', 'CAMK2D', 'CRCP', 'RGS14', 'YWHAB', 'LPAR1', 'ITPR1', 'ATP2A2', 'ADCY3', 'ADCY8', 'PRKCZ', 'ACTG1', 'RGS4', 'RGS2', 'GNG3', 'YWHAQ', 'GNG4', 'PDE4B', 'NOS1', 'PRKACA', 'RGS7', 'YWHAH', 'GSTO1', 'IGFBP3', 'PDE4D', 'FOS', 'NFKB1', 'CREB3', 'PRKAR1A', 'GNB1', 'GNB4', 'PRKD1', 'GNB5', 'ATF5', 'CALM1', 'CALM2', 'ATF4']",0.9995105235655231,0,0,39
18,Purine metabolism WP4792,0.040284841397599136,4.001144819690898,12.850797008093437,"['PRPS1', 'DGUOK', 'ATIC', 'ITPA', 'APRT']",0.9995105235655231,0,0,5
19,Cytosolic DNA-sensing pathway WP4655,0.04208936311291729,1.8309339239571798,5.800325850949803,"['NLRX1', 'POLR3GL', 'ADAR', 'ISG15', 'NFKB1', 'NFKBIA', 'POLR3A', 'POLR3C', 'POLR3D', 'POLR1C', 'POLR1D', 'POLR2E', 'TRIM25', 'POLR2F', 'POLR3H', 'NFKBIB']",0.9995105235655231,0,0,16
20,Biomarkers for pyrimidine metabolism disorders WP4584,0.04378598151352716,3.201259662181506,10.014953802244662,"['RRM1', 'RRM2B', 'TK2', 'CKB', 'UMPS', 'DHODH']",0.9995105235655231,0,0,6
21,Purine metabolism and related disorders WP4224,0.04388591737096098,2.561558292752793,8.007845681179411,"['PRPS1', 'DGUOK', 'GRM5', 'ATIC', 'RRM2B', 'PFAS', 'ITPA', 'APRT']",0.9995105235655231,0,0,8
22,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.047316163261625854,1.6415868385250845,5.008322742047507,"['HSPA9', 'HSPA8', 'HSPA5', 'PSMD13', 'HSPA4', 'UBE2L6', 'UBE2G2', 'HSPA2', 'UBE2J2', 'HSPA14', 'TUBA4A', 'TUBB8', 'PSMC5', 'TUBA1A', 'PSMD7', 'TUBB2A', 'PSMD4', 'PSMC3', 'PSMD2', 'RNF19A', 'PSMC1']",0.9995105235655231,0,0,21
23,16p11.2 proximal deletion syndrome WP4949,0.05929182716139716,1.5667785127664333,4.426593957162749,"['CCT3', 'CCT2', 'PCNA', 'PRRT2', 'IGFBP3', 'QPRT', 'TRAF2', 'PPP2R5D', 'KIF22', 'NFKB1', 'CCT6A', 'PPP2CB', 'PPP4R1', 'HIRIP3', 'PPP4R4', 'TMEM219', 'PPARG', 'CCT8', 'ALDOA', 'CCT5', 'CCT4', 'MAPK3']",0.9995105235655231,0,0,22
24,7q11.23 copy number variation syndrome WP4932,0.06116237882049624,1.4714708757810617,4.111617770293921,"['BECN1', 'PCNA', 'CLTC', 'ATP5MC2', 'DDX21', 'UBE2L6', 'ACACB', 'FBLN5', 'GRIP1', 'ATP5F1A', 'NUP62', 'BUD23', 'SF3B1', 'PRKG1', 'EIF2A', 'MAPK3', 'ATP5PB', 'UBE2E1', 'VPS37C', 'HSPA2', 'DEK', 'MYBBP1A', 'DNAJC30', 'GRB2', 'SQSTM1', 'GAPDH', 'ATF4', 'FBN1']",0.9995105235655231,0,0,28
25,Exercise-induced Circadian Regulation WP410,0.06186666496608946,1.7085654129581778,4.754551023686301,"['DAZAP2', 'HSPA8', 'GSTM3', 'BTG1', 'G0S2', 'QKI', 'PPP2CB', 'PSMA4', 'SUMO1', 'STBD1', 'KLF9', 'CRY2', 'CRY1', 'TAB2', 'ERC2', 'EIF4G2']",0.9995105235655231,0,0,16
26,Pregnane X receptor pathway WP2876,0.06338996839245116,2.489913452971872,6.868300911073385,"['NCOA1', 'NCOA2', 'ABCC4', 'HSP90AA1', 'PSMC5', 'DNAJC7', 'NCOA3']",0.9995105235655231,0,0,7
27,Glycolysis and Gluconeogenesis WP534,0.06350164503473511,1.957027268093782,5.394916457290887,"['PDHA1', 'MDH2', 'MPC2', 'GOT2', 'PGK1', 'SLC2A3', 'ENO2', 'ALDOA', 'PFKM', 'GAPDH', 'GCK']",0.9995105235655231,0,0,11
28,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.06532138919839957,2.7436914645617767,7.485985861114512,"['CDK8', 'JAG1', 'H2AFY', 'CCND1', 'CDH1', 'SOX4']",0.9995105235655231,0,0,6
29,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.06765196352382276,1.7160078727242907,4.621859396705266,"['MBTPS1', 'PPP1R11', 'HSPA5', 'PPP1R10', 'EIF2AK1', 'EIF2AK2', 'EIF2S1', 'ERN1', 'PPP1R2', 'PPP1R3F', 'MAP1LC3A', 'PPP1R7', 'PPP1R3E', 'PPP1R8', 'ATF4']",0.9995105235655231,0,0,15
30,DNA Repair Pathways Full Network WP4946,0.06919298990332863,1.3854852735722636,3.700431272696847,"['FEN1', 'MRE11', 'DCLRE1C', 'PCNA', 'MPG', 'PRKDC', 'CETN2', 'POLD4', 'RAP1A', 'NTHL1', 'POLD2', 'REV3L', 'USP1', 'MUTYH', 'MBD4', 'XRCC6', 'PARP1', 'XRCC5', 'MGMT', 'REV1', 'RPA1', 'RPA2', 'APEX2', 'LIG3', 'FANCC', 'RAD23A', 'GTF2H3', 'TERF2', 'GTF2H5', 'RBX1', 'FANCF', 'DDB1', 'POLE4', 'MSH2', 'APEX1']",0.9995105235655231,0,0,35
31,Splicing factor NOVA regulated synaptic proteins WP4148,0.07404315601898508,1.7246220064010596,4.489375904057673,"['NTNG1', 'CADM3', 'CADM1', 'EPB41', 'APLP2', 'CLSTN1', 'ANK3', 'EFNA5', 'PRKCZ', 'DAB1', 'CDH2', 'EPB41L1', 'EPB41L3', 'MAP4']",0.9995105235655231,0,0,14
32,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.07538624362001381,1.4422811059907834,3.728484827591574,"['NDUFB8', 'NDUFB6', 'NDUFA12', 'COX15', 'NDUFB4', 'ATP5MC2', 'NDUFB1', 'ATP5F1A', 'COX11', 'NDUFV3', 'NDUFV1', 'ATP5MG', 'NDUFA9', 'NDUFA8', 'SURF1', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFC2', 'SDHC', 'COX7A2L', 'SCO1', 'NDUFAB1', 'NDUFS3', 'NDUFS1', 'UQCRC2', 'SLC25A4']",0.9995105235655231,0,0,27
33,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.08036143183721658,2.134249976129094,5.3809156913332545,"['NFKBIA', 'PPP3CA', 'GSK3A', 'RASA1', 'DYRK1A', 'CALM1', 'CALM2', 'NFKB1']",0.9995105235655231,0,0,8
34,Proximal tubule transport WP4917,0.0811167601728721,1.7347007075922738,4.357335170103443,"['ATP6V1A', 'ABCC4', 'SLC22A6', 'SLC1A1', 'SLC3A1', 'SLC3A2', 'ATP1A1', 'SLC4A4', 'FXYD2', 'ATP6V1E1', 'ATP6V0C', 'ATP6V1D', 'ATP6V1C1']",0.9995105235655231,0,0,13
35,Ras signaling WP4223,0.08223377059949637,1.3132964065255732,3.28086293430597,"['RAB5B', 'RAB5C', 'FLT1', 'RALB', 'RASGRF1', 'RASAL2', 'PLA2G6', 'IGF1R', 'CDC42', 'RASSF1', 'GNG10', 'GNG3', 'RAP1A', 'GNG4', 'AKT3', 'RAC3', 'RAC1', 'PRKACA', 'RALGDS', 'MAPK3', 'NTRK2', 'RALBP1', 'PLA2G4C', 'GAB1', 'PTPN11', 'NFKB1', 'RHOA', 'MAPK10', 'AFDN', 'MRAS', 'PIK3CA', 'RASA1', 'GNB1', 'NF1', 'GNB4', 'GRB2', 'GNB5', 'RGL1', 'CALM1', 'CALM2', 'FGFR2', 'EXOC2', 'FGFR1']",0.9995105235655231,0,0,43
36,Rett syndrome causing genes WP4312,0.0871498835559462,1.601492965834051,3.9078443735557626,"['HDAC5', 'EIF2B2', 'CDKL5', 'STXBP1', 'GABRA3', 'BRAF', 'SMARCA1', 'MECP2', 'GNAO1', 'XAB2', 'SCN8A', 'IMPDH2', 'HIVEP2', 'SCN2A', 'CRK', 'SCN1A']",0.9995105235655231,0,0,16
37,miR-517 relationship with ARCN1 and USP1 WP3596,0.09146567190641643,4.799485125858124,11.479367956457999,"['ID2', 'USP1', 'ARCN1']",0.9995105235655231,0,0,3
38,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.09146567190641643,4.799485125858124,11.479367956457999,"['RIPPLY2', 'DLL1', 'DLL3']",0.9995105235655231,0,0,3
39,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.09491059009052491,1.9208595988538681,4.523278576542564,"['CCND2', 'CCND1', 'CDH1', 'PDGFA', 'FGF1', 'NFKB1', 'GTPBP4', 'RUNX2', 'FGFR2']",0.9995105235655231,0,0,9
40,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.09654850331389477,2.6669528715893915,6.2345617891016465,"['GALNT3', 'CCND1', 'FAM20C', 'NFKB1', 'FGFR2']",0.9995105235655231,0,0,5
41,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.09654850331389477,2.6669528715893915,6.2345617891016465,"['SFRP1', 'CCND1', 'NRG3', 'ERBB4', 'CDH1']",0.9995105235655231,0,0,5
42,RalA downstream regulated genes WP2290,0.09654850331389477,2.6669528715893915,6.2345617891016465,"['CDC42', 'RALBP1', 'RAC3', 'RAC1', 'EXOC2']",0.9995105235655231,0,0,5
43,PDGF Pathway WP2526,0.09747875261826071,1.6651635111876075,3.8767018833781153,"['STAT1', 'PDGFA', 'PTPN11', 'FOS', 'NFKB1', 'RHOA', 'CDC42', 'NFKBIA', 'RASA1', 'ARFIP2', 'GRB2', 'RAC1', 'MAPK3']",0.9995105235655231,0,0,13
44,Heme Biosynthesis WP561,0.09811689647382778,3.2,7.429106207987201,"['ALAD', 'FECH', 'UROD', 'UROS']",0.9995105235655231,0,0,4
45,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.09811689647382778,3.2,7.429106207987201,"['ZYG11B', 'CUL2', 'ELOC', 'RBX1']",0.9995105235655231,0,0,4
46,Type II interferon signaling (IFNG) WP619,0.10374208349887613,1.9699006235815173,4.463494258221478,"['STAT1', 'IFNGR2', 'IFI6', 'TAP1', 'EIF2AK2', 'PTPN11', 'ISG15', 'IRF9']",0.9995105235655231,0,0,8
47,Methionine De Novo and Salvage Pathway WP3580,0.113328273037008,2.036837446631261,4.43514551111567,"['ADI1', 'AMD1', 'MSRB2', 'SMS', 'TXN', 'MAT2B', 'SRM']",0.9995105235655231,0,0,7
48,Glycosylation and related congenital defects WP4521,0.11827287147044856,1.800644699140401,3.8439458158172264,"['DPM2', 'ALG8', 'MPI', 'SRD5A3', 'ALG14', 'ALG3', 'ALG13', 'MAGT1', 'ALG11']",0.9995105235655231,0,0,9
49,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.11827287147044856,1.800644699140401,3.8439458158172264,"['RAB3B', 'FGD4', 'RAB3A', 'RAB4B', 'SH3TC2', 'HSPB8', 'MPZ', 'MFN2', 'SBF2']",0.9995105235655231,0,0,9
50,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.12359062048003462,2.1336005344021376,4.460890654383808,"['EGLN2', 'CCND1', 'CFLAR', 'NFKB1', 'BCL2L2', 'BIRC2']",0.9995105235655231,0,0,6
51,Genotoxicity pathway WP4286,0.12990823084145747,1.5009687141216992,3.0633675664115994,"['PRKAB2', 'NLRX1', 'CEBPD', 'EI24', 'SEL1L', 'PCDH8', 'ITPR1', 'CBLB', 'TM7SF3', 'COIL', 'MEX3B', 'RRM2B', 'BLOC1S2', 'ID2', 'RAPGEF2']",0.9995105235655231,0,0,15
52,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.13046500204764505,1.829029749969309,3.7250939372772023,"['MBTPS1', 'ADAMTS2', 'CRTAP', 'BMP1', 'ITPR1', 'PLOD2', 'P4HB', 'PPIB']",0.9995105235655231,0,0,8
53,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.13356932871408347,1.4150962309542903,2.8487792127827665,"['EGR1', 'CDKN1B', 'STAT1', 'PDE4D', 'ADCY3', 'BRAF', 'TTF2', 'FOS', 'TTF1', 'IGF1R', 'GNAI2', 'GNAO1', 'RAP1A', 'PIK3CA', 'APEX1', 'GNB1', 'PLCB1', 'RALGDS', 'MAPK3']",0.9995105235655231,0,0,19
54,Cell Differentiation - Index expanded WP2023,0.13423603559291433,2.2857551721318177,4.590151978134553,"['SOX2', 'HDAC5', 'ID2', 'MEF2D', 'RUNX2']",0.9995105235655231,0,0,5
55,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.13423603559291433,2.2857551721318177,4.590151978134553,"['RYR2', 'CCKBR', 'ITPR1', 'CCK', 'PLCB1']",0.9995105235655231,0,0,5
56,3q29 copy number variation syndrome WP4906,0.1412945962850032,1.4325553976843315,2.8033794517779835,"['DYNC2H1', 'DYNLT1', 'NCBP2', 'CEP350', 'PXN', 'RNF8', 'PIGZ', 'MAD2L1BP', 'WDR53', 'FBXO45', 'DYNLL1', 'DYNLL2', 'PIGX', 'DYNC2LI1', 'DLG1', 'TCTEX1D2', 'UBE2N']",0.9995105235655231,0,0,17
57,let-7 inhibition of ES cell reprogramming WP3299,0.1432086224047921,6.398055476122391,12.434318918841887,"['SOX2', 'EGR1']",0.9995105235655231,0,0,2
58,Nanomaterial-induced inflammasome activation WP3890,0.1432086224047921,6.398055476122391,12.434318918841887,"['NFKB1', 'CTSB']",0.9995105235655231,0,0,2
59,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.1432086224047921,6.398055476122391,12.434318918841887,"['CHRM1', 'CCKBR']",0.9995105235655231,0,0,2
60,Thiamine metabolic pathways WP4297,0.14438256150523454,2.5597711015736766,4.953896407472697,"['BCKDK', 'PDHA1', 'SLC25A19', 'TKT']",0.9995105235655231,0,0,4
61,Pathogenic Escherichia coli infection WP2272,0.1493438468255018,1.455354347145392,2.7673620177185123,"['ROCK2', 'ARPC4', 'ARPC5', 'TUBA4A', 'RHOA', 'ACTG1', 'TUBB8', 'CDC42', 'TUBA1A', 'TUBB2A', 'YWHAQ', 'ARPC2', 'CDH1', 'ARPC3', 'NCL']",0.9995105235655231,0,0,15
62,Synaptic Vesicle Pathway WP2267,0.1493438468255018,1.455354347145392,2.7673620177185123,"['NAPA', 'RAB3A', 'SYT1', 'STXBP1', 'CLTC', 'CLTA', 'SYP', 'AP2B1', 'SYN3', 'CPLX2', 'AP2A2', 'DNM3', 'AP2S1', 'STX3', 'SLC25A4']",0.9995105235655231,0,0,15
63,Cellular Proteostasis WP4918,0.15123033875548555,3.199370709382151,6.0434550838478005,"['PFDN1', 'PFDN2', 'PFDN4']",0.9995105235655231,0,0,3
64,G Protein Signaling Pathways WP35,0.1514812837853111,1.3253287025551972,2.5012838494692446,"['PDE1C', 'PDE4D', 'ITPR1', 'ADCY3', 'AKAP6', 'AKAP5', 'ADCY8', 'PRKCZ', 'RHOA', 'GNAI2', 'GNAO1', 'PPP3CA', 'GNG10', 'GNG3', 'GNAL', 'PRKAR1A', 'GNG4', 'GNB1', 'PDE4B', 'PRKD1', 'GNB5', 'PRKACA', 'CALM1', 'CALM2']",0.9995105235655231,0,0,24
65,Urea cycle and metabolism of amino groups WP497,0.15971102163225487,1.920068708846264,3.522153324920423,"['ACY1', 'SMS', 'PYCR1', 'PYCR3', 'CKB', 'SRM']",0.9995105235655231,0,0,6
66,Cell migration and invasion through p75NTR WP4561,0.1603285938567865,1.7069416595053948,3.124607673804073,"['NTRK2', 'ARF1', 'TRIO', 'EFNB3', 'AKT3', 'RAC1', 'EFNA5', 'RHOA']",0.9995105235655231,0,0,8
67,Airway smooth muscle cell contraction WP4962,0.17730769975565372,1.9998568975386377,3.459489729554064,"['ROCK2', 'PLCB1', 'CALM1', 'CALM2', 'RHOA']",0.9995105235655231,0,0,5
68,NOTCH1 regulation of endothelial cell calcification WP3413,0.17730769975565372,1.9998568975386377,3.459489729554064,"['JAG1', 'LPAR1', 'SOX6', 'DLL1', 'DLL3']",0.9995105235655231,0,0,5
69,Pyrimidine metabolism and related diseases WP4225,0.17730769975565372,1.9998568975386377,3.459489729554064,"['RRM1', 'RRM2B', 'TK2', 'UMPS', 'DHODH']",0.9995105235655231,0,0,5
70,VEGFA-VEGFR2 Signaling Pathway WP3888,0.18072199227085378,1.1225521905321965,1.920457104523538,"['RPL5', 'FHOD1', 'ACTG1', 'TUBB8', 'PSMD4', 'CCND1', 'ATP6V1E1', 'EIF2A', 'TPM3', 'IGFBP3', 'SARS', 'TMEM170A', 'PDIA6', 'SND1', 'ERN1', 'KATNAL2', 'NCL', 'FSCN1', 'TFAM', 'PRKD1', 'ATP6V0D1', 'VCL', 'ATF4', 'LRRC59', 'EPB41', 'PXN', 'HTRA1', 'TXN', 'PRKCZ', 'ACACB', 'STIP1', 'RAP1A', 'FXR2', 'DHX36', 'PGK1', 'MYH11', 'MAP2K7', 'TXNDC5', 'EGR1', 'JAG1', 'EGR3', 'IDH2', 'NFKB1', 'QKI', 'NFKBIA', 'AFDN', 'NR4A1', 'BMP2', 'TFCP2', 'HYOU1', 'TPP1', 'GRB2', 'GRSF1', 'EIF4G2', 'EIF4G1', 'YWHAE', 'ARF4', 'FLT1', 'CLTC', 'SRP54', 'LDB2', 'PPP3CA', 'RACK1', 'ELOC', 'RAC1', 'ACP1', 'PRKG1', 'HSP90AA1', 'SSR3', 'GAB1', 'SHROOM2', 'RHOA', 'EPN1', 'RCN1', 'PIK3CA', 'TKT', 'ALDOA', 'GAPDH', 'CRK', 'PTMA', 'ENG', 'NAPA', 'HDAC5', 'ROCK2', 'CAMKK2', 'CDC42', 'AP2S1', 'DNAJB9', 'RICTOR', 'ASCC3', 'ABCF2', 'MAPK3', 'STAT1', 'PTPN11', 'PTPN14', 'P4HB', 'EIF3F', 'EIF3D']",0.9995105235655231,0,0,98
71,Eukaryotic Transcription Initiation WP405,0.1811158149699013,1.4349714127445743,2.4518188328356385,"['GTF2A2', 'TAF12', 'ILK', 'GTF2H3', 'POLR2A', 'POLR2C', 'POLR3D', 'POLR2E', 'POLR1D', 'POLR2F', 'POLR1E', 'POLR2G', 'POLR3H']",0.9995105235655231,0,0,13
72,Gastrin signaling pathway WP4659,0.19182980325319907,1.2454303914978073,2.056388332643643,"['CDKN1B', 'PXN', 'ELAVL1', 'CDC42', 'CCND1', 'CDH1', 'EIF4EBP1', 'RAC1', 'PRKACA', 'MEF2D', 'MAPK3', 'EGR1', 'JAG1', 'PTPN11', 'FOS', 'NFKB1', 'RHOA', 'RHOB', 'NFKBIA', 'TJP1', 'BMP2', 'CCKBR', 'PIK3CA', 'GRB2', 'PPARG', 'PRKD1', 'CRK', 'BIRC2']",0.9995105235655231,0,0,28
73,p53 transcriptional gene network WP4963,0.1925568292622773,1.3719452189601444,2.260093097662678,"['PRKAB2', 'SIVA1', 'XRCC5', 'MGMT', 'FUCA1', 'FANCC', 'ISG15', 'PML', 'BBC3', 'RRM2B', 'MSH2', 'SESN1', 'SESN2', 'ULK2', 'IRF9']",0.9995105235655231,0,0,15
74,Non-homologous end joining WP438,0.19725650023013164,2.1329518359561277,3.462314847367775,"['XRCC6', 'DCLRE1C', 'PRKDC', 'XRCC5']",0.9995105235655231,0,0,4
75,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.1997409087854992,1.7453608515732764,2.811312429518146,"['RAB5B', 'RAB5C', 'MRAS', 'RAB27A', 'BRAF', 'MAPK3']",0.9995105235655231,0,0,6
76,Metabolic reprogramming in colon cancer WP4290,0.19995967600565678,1.4225536118280597,2.2897985594828487,"['PDHA1', 'MDH2', 'GOT2', 'IDH2', 'PGK1', 'PYCR1', 'TALDO1', 'PYCR2', 'PDHB', 'TKT', 'GAPDH', 'GLS']",0.9995105235655231,0,0,12
77,GABA receptor Signaling WP4159,0.2044596479061119,1.5159251998190317,2.4063563832240726,"['GABRB1', 'GABBR1', 'GABRA6', 'GABRA4', 'GABRA3', 'AP2S1', 'AP2B1', 'SLC6A1', 'AP2A2']",0.9995105235655231,0,0,9
78,The influence of laminopathies on Wnt signaling WP4844,0.2044596479061119,1.5159251998190317,2.4063563832240726,"['WNT10B', 'CDK6', 'CEBPD', 'CCND1', 'FNTA', 'PPARG', 'EMD', 'TOR1AIP1', 'RUNX2']",0.9995105235655231,0,0,9
79,Endochondral Ossification with Skeletal Dysplasias WP4808,0.21155459440471383,1.3579409590887352,2.1092519195823938,"['THRA', 'STAT1', 'IGF1', 'GLI3', 'RUNX2', 'IGF1R', 'GHR', 'ADAMTS5', 'SOX6', 'PRKACA', 'CALM1', 'SLC38A2', 'CALM2', 'FGFR1']",0.9995105235655231,0,0,14
80,Endochondral Ossification WP474,0.21155459440471383,1.3579409590887352,2.1092519195823938,"['THRA', 'STAT1', 'IGF1', 'GLI3', 'RUNX2', 'IGF1R', 'GHR', 'ADAMTS5', 'SOX6', 'PRKACA', 'CALM1', 'SLC38A2', 'CALM2', 'FGFR1']",0.9995105235655231,0,0,14
81,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.21349897726522132,1.2685397159503944,1.958781652014632,"['THRA', 'ADCY3', 'SIRT6', 'TTF2', 'TTF1', 'ADCY8', 'CASP9', 'CREB3', 'RPS6KA6', 'TBC1D4', 'PIK3CA', 'AKT3', 'ZNF516', 'PRKG2', 'PPARG', 'GRB2', 'PRKACA', 'PLCB1', 'MAP4K5', 'MGLL', 'FGFR1']",0.9995105235655231,0,0,21
82,Unfolded protein response WP4925,0.21597536439040127,1.5999427262313861,2.4520577132227865,"['ERN1', 'MBTPS1', 'HSPA5', 'RTCB', 'EIF2S1', 'BBC3', 'ATF4']",0.9995105235655231,0,0,7
83,G1 to S cell cycle control WP45,0.21616177970935652,1.3337160352085726,2.0428904239205403,"['CDKN2D', 'CDKN1B', 'PCNA', 'RPA1', 'RPA2', 'CREB3', 'CCND2', 'ORC6', 'CDK6', 'CCND1', 'CCNE2', 'ORC3', 'CCNG2', 'MCM4', 'MCM6']",0.9995105235655231,0,0,15
84,"Cerebral organic acidurias, including diseases WP4519",0.21952964223980528,2.3993135011441646,3.6380023106537047,"['GCDH', 'MDH2', 'IDH2']",0.9995105235655231,0,0,3
85,Dual hijack model of Vif in HIV infection WP3300,0.21952964223980528,2.3993135011441646,3.6380023106537047,"['UBB', 'ELOC', 'RBX1']",0.9995105235655231,0,0,3
86,Pentose Phosphate Metabolism WP134,0.21952964223980528,2.3993135011441646,3.6380023106537047,"['TALDO1', 'PGLS', 'TKT']",0.9995105235655231,0,0,3
87,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.2247085235358501,1.777491572855053,2.653708119006825,"['RPH3A', 'MADD', 'RAB27A', 'GCC2', 'UNC13D']",0.9995105235655231,0,0,5
88,Transcription co-factors SKI and SKIL protein partners WP4533,0.2247085235358501,1.777491572855053,2.653708119006825,"['MECP2', 'PRMT5', 'ING2', 'NF1', 'TEAD1']",0.9995105235655231,0,0,5
89,Gastric Cancer Network 2 WP2363,0.22822100229398587,1.5058553928589482,2.2248122131704258,"['OTUD5', 'AHCTF1', 'DSCC1', 'UBE2T', 'RAD17', 'BRIX1', 'CACYBP', 'CEBPZ']",0.9995105235655231,0,0,8
90,Sphingolipid pathway WP1422,0.22822100229398587,1.5058553928589482,2.2248122131704258,"['UGCG', 'ASAH1', 'SGPL1', 'GAL3ST1', 'SERINC1', 'KDSR', 'SGPP2', 'PLPP1']",0.9995105235655231,0,0,8
91,Spinal Cord Injury WP2431,0.23554340888078296,1.2355983429958273,1.7865022894642033,"['EGR1', 'SEMA6A', 'CDKN1B', 'ROCK2', 'NCAN', 'OMG', 'FOS', 'PLA2G6', 'RHOA', 'RHOB', 'CDC42', 'NR4A1', 'PPP3CA', 'CCND1', 'COL4A1', 'PTPRA', 'APEX1', 'NOS1', 'RAC1', 'LTB', 'SLIT2', 'MAPK3']",0.9995105235655231,0,0,22
92,Gene regulatory network modelling somitogenesis  WP2854,0.24201742181094907,3.1987417786674293,4.538200710344792,"['RIPPLY2', 'DLL1']",0.9995105235655231,0,0,2
93,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.24201742181094907,3.1987417786674293,4.538200710344792,"['SLIT2', 'RAC1']",0.9995105235655231,0,0,2
94,Vitamin B6-dependent and responsive disorders WP4228,0.24201742181094907,3.1987417786674293,4.538200710344792,"['PNPO', 'PIGV']",0.9995105235655231,0,0,2
95,Disruption of postsynaptic signaling by CNV WP4875,0.2452945356851724,1.3913292708761698,1.9552289080994547,"['RPH3A', 'TJP1', 'RYR2', 'CAMK2D', 'DLG1', 'ARC', 'DLG2', 'NRXN3', 'DLGAP1', 'MAPK3']",0.9995105235655231,0,0,10
96,Cancer immunotherapy by PD-1 blockade WP4585,0.254803927420853,1.828080931943593,2.499463656445934,"['PTPN11', 'HLA-A', 'PDCD1LG2', 'NFKB1']",0.9995105235655231,0,0,4
97,Computational Model of Aerobic Glycolysis WP4629,0.254803927420853,1.828080931943593,2.499463656445934,"['PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.9995105235655231,0,0,4
98,Cysteine and methionine catabolism WP4504,0.254803927420853,1.828080931943593,2.499463656445934,"['GSS', 'ETHE1', 'SUOX', 'CDO1']",0.9995105235655231,0,0,4
99,Homologous recombination WP186,0.254803927420853,1.828080931943593,2.499463656445934,"['POLD4', 'MRE11', 'POLD2', 'RPA1']",0.9995105235655231,0,0,4
100,"NAD metabolism, sirtuins and aging WP3630",0.254803927420853,1.828080931943593,2.499463656445934,"['PARP1', 'TFAM', 'PPARG', 'NFKB1']",0.9995105235655231,0,0,4
101,Physiological and pathological hypertrophy of the heart WP1528,0.25588019912846405,1.4931462390225276,2.035226883374344,"['PPP3CA', 'CAMK2D', 'RAC1', 'FOS', 'CALM1', 'CALM2', 'RHOA']",0.9995105235655231,0,0,7
102,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.2605112389289589,1.3000932300631096,1.7487674621722005,"['EIF4A2', 'EIF4A1', 'CSNK2A1', 'MAPK10', 'PIK3CA', 'AKT3', 'EIF4EBP1', 'MAP2K7', 'PRKACA', 'EIF4G3', 'EIF4B', 'MAPK3', 'EIF4G1']",0.9995105235655231,0,0,13
103,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.27526747218406056,1.5995993131081854,2.0635023537077735,"['TJP1', 'PXN', 'ITPR1', 'VCL', 'MAPK3']",0.9995105235655231,0,0,5
104,Overview of interferons-mediated signaling pathway WP4558,0.27526747218406056,1.5995993131081854,2.0635023537077735,"['PIK3CA', 'STAT1', 'IFNGR2', 'IRF9', 'IFNAR1']",0.9995105235655231,0,0,5
105,DNA Replication WP466,0.2784289165962999,1.3332377949746823,1.7046678304805987,"['POLD4', 'PCNA', 'ORC6', 'ORC3', 'UBC', 'POLD2', 'RPA1', 'RPA2', 'MCM4', 'MCM6']",0.9995105235655231,0,0,10
106,Signaling of Hepatocyte Growth Factor Receptor WP313,0.2784289165962999,1.3332377949746823,1.7046678304805987,"['RAP1A', 'PIK3CA', 'RASA1', 'PXN', 'GAB1', 'PTPN11', 'GRB2', 'FOS', 'CRK', 'MAPK3']",0.9995105235655231,0,0,10
107,Target Of Rapamycin (TOR) Signaling WP1471,0.2784289165962999,1.3332377949746823,1.7046678304805987,"['CDC42', 'PRKAB2', 'RRAGA', 'RRAGC', 'RRAGD', 'PRKAG1', 'EIF4EBP1', 'ULK2', 'RICTOR', 'RAC1']",0.9995105235655231,0,0,10
108,Genes related to primary cilium development (based on CRISPR) WP4536,0.27935575208197594,1.16794588367169,1.4894454271241477,"['C2CD3', 'ARL6', 'ARL3', 'FBF1', 'TXNDC15', 'HSPB11', 'DYNC2LI1', 'KIF3B', 'TCTN3', 'TTC21B', 'TCTEX1D2', 'TMEM107', 'TCTN1', 'BBS9', 'KIFAP3', 'IFT57', 'BBS4', 'DYNC2H1', 'MKKS', 'DYNLT1', 'WDR19', 'DYNLL1', 'IFT20', 'TMEM17', 'IFT43', 'CEP83', 'CLUAP1']",0.9995105235655231,0,0,27
109,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.2885259715476587,1.4765795326917572,1.8353443192509598,"['B3GALNT1', 'UGCG', 'SGPL1', 'GALNT1', 'KDSR', 'SGPP2']",0.9995105235655231,0,0,6
110,ATR Signaling WP3875,0.29237728380380223,1.919279176201373,2.3601572619478497,"['RPA1', 'HUS1', 'ATRIP']",0.9995105235655231,0,0,3
111,Canonical NF-KB pathway WP4562,0.29237728380380223,1.919279176201373,2.3601572619478497,"['NFKBIA', 'NFKBIE', 'NFKB1']",0.9995105235655231,0,0,3
112,"Degradation pathway of sphingolipids, including diseases WP4153",0.29237728380380223,1.919279176201373,2.3601572619478497,"['NEU3', 'HEXB', 'NEU1']",0.9995105235655231,0,0,3
113,Leptin and adiponectin WP3934,0.29237728380380223,1.919279176201373,2.3601572619478497,"['PRKAG1', 'LEPR', 'ADIPOR1']",0.9995105235655231,0,0,3
114,Mitochondrial CII Assembly WP4920,0.29237728380380223,1.919279176201373,2.3601572619478497,"['SDHAF3', 'SDHAF4', 'SDHC']",0.9995105235655231,0,0,3
115,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.29237728380380223,1.919279176201373,2.3601572619478497,"['CAMK2D', 'CCND2', 'MEF2D']",0.9995105235655231,0,0,3
116,DNA damage response WP707,0.2935670988318815,1.2307913097235714,1.508518199166841,"['CDKN1B', 'MRE11', 'PRKDC', 'RPA2', 'PML', 'BBC3', 'CASP9', 'CCND2', 'CDK6', 'CCND1', 'RRM2B', 'CCNE2', 'SESN1', 'RAD17', 'ATRIP']",0.9995105235655231,0,0,15
117,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.2950682950212688,1.21909136896217,1.487960069688759,"['PXN', 'PTPN11', 'NFKB1', 'CASP9', 'NFKBIA', 'PIK3CA', 'MSH2', 'TNIP1', 'RASA1', 'STMN1', 'EIF4EBP1', 'GRB2', 'NOS1', 'RAC1', 'CRK', 'MAPK3']",0.9995105235655231,0,0,16
118,Calcium Regulation in the Cardiac Cell WP536,0.2966056719984908,1.1358729035980866,1.3804850939814952,"['YWHAE', 'RYR2', 'RGS17', 'CAMK2D', 'CHRM1', 'RGS14', 'YWHAB', 'ITPR1', 'ATP2A2', 'ADCY3', 'ADCY8', 'PRKCZ', 'GNAI2', 'RGS4', 'RGS2', 'GNG3', 'YWHAQ', 'GNG4', 'PRKACA', 'RGS7', 'YWHAH', 'KCNB1', 'ATP2B3', 'ATP1B2', 'GNAO1', 'PRKAR1A', 'FXYD2', 'GNB1', 'GNB4', 'PRKD1', 'GNB5', 'CALM1', 'CALM2']",0.9995105235655231,0,0,33
119,DNA Mismatch Repair WP531,0.29768402177912556,1.3996993127147765,1.6960474088692639,"['POLE4', 'POLD4', 'PCNA', 'MSH2', 'POLD2', 'RPA1', 'RPA2']",0.9995105235655231,0,0,7
120,miRNA regulation of prostate cancer signaling pathways WP3981,0.3091243435314684,1.3088564730398542,1.5366127825744287,"['CASP9', 'NFKBIA', 'CDKN1B', 'CCND1', 'PIK3CA', 'AKT3', 'PDGFA', 'GRB2', 'NFKB1']",0.9995105235655231,0,0,9
121,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.3128548774782264,1.120323325635104,1.3018334572446015,"['RAB3A', 'RASGRF1', 'YBX1', 'ACACB', 'CDC42', 'GRIP1', 'RAP1A', 'CDH2', 'DPYSL2', 'EIF4EBP1', 'RACK1', 'KCNN2', 'RAC1', 'SH2B1', 'MAPK3', 'VAV3', 'EGR1', 'NTRK2', 'CDKL5', 'CSNK2A1', 'STAT1', 'PTPN11', 'FOS', 'EIF2S2', 'EEF2', 'EIF2S1', 'NFKB1', 'NFKBIA', 'MAPK10', 'DLG1', 'BMP2', 'MARCKS', 'GRB2', 'MAPT', 'SQSTM1']",0.9995105235655231,0,0,35
122,Hedgehog Signaling Pathway Netpath WP47,0.3150878648122451,1.5994277539341917,1.8471850999006065,"['STK36', 'SAP18', 'KIF7', 'GLI3']",0.9995105235655231,0,0,4
123,NO metabolism in cystic fibrosis WP4947,0.3150878648122451,1.5994277539341917,1.8471850999006065,"['PRMT5', 'PRMT2', 'PRMT1', 'NOS1']",0.9995105235655231,0,0,4
124,DNA IR-double strand breaks and cellular response via ATM WP3959,0.3202788101036055,1.2107022373880336,1.378461232736428,"['UPF1', 'MRE11', 'DCLRE1C', 'PCNA', 'PARP1', 'PRKDC', 'RNF8', 'TERF2', 'CASP9', 'RASSF1', 'HSF1', 'NABP2', 'RAD17', 'MCPH1']",0.9995105235655231,0,0,14
125,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.3277931226554015,1.454051100588021,1.6218087467072844,"['NFKBIA', 'NLRX1', 'ITPR1', 'NFKBIE', 'NFKB1']",0.9995105235655231,0,0,5
126,Canonical and non-canonical Notch signaling WP3845,0.3356524068844783,1.3709868717025888,1.4966777934644955,"['JAG1', 'MFAP1', 'PSEN2', 'DLL1', 'DLL3', 'DLK2']",0.9995105235655231,0,0,6
127,Metastatic brain tumor WP2249,0.34238523247875097,2.1323038795157756,2.2854433109339936,"['CDC42', 'CDK6']",0.9995105235655231,0,0,2
128,Mitochondrial fatty acid synthesis pathway WP4317,0.34238523247875097,2.1323038795157756,2.2854433109339936,"['MECR', 'HSD17B12']",0.9995105235655231,0,0,2
129,"Phase I biotransformations, non P450 WP136",0.34238523247875097,2.1323038795157756,2.2854433109339936,"['ESD', 'CES2']",0.9995105235655231,0,0,2
130,The alternative pathway of fetal androgen synthesis WP4524,0.34238523247875097,2.1323038795157756,2.2854433109339936,"['STAR', 'HSD17B6']",0.9995105235655231,0,0,2
131,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.34419163537488445,1.2796333428816957,1.364801511736436,"['CREB3', 'CAMK2D', 'STAR', 'ITPR1', 'CALM1', 'CALM2', 'CAMK1G', 'ATF4']",0.9995105235655231,0,0,8
132,TNF-alpha signaling pathway WP231,0.34518048243707083,1.1389216479371547,1.211457131815049,"['HSP90AA1', 'CSNK2A1', 'TRAF2', 'TXN', 'CFLAR', 'PRKCZ', 'NFKB1', 'CASP9', 'NFKBIA', 'PSMD2', 'CDC37', 'MADD', 'GRB2', 'TAB2', 'RAC1', 'MAP2K7', 'NFKBIE', 'BIRC2', 'SKP1', 'MAPK3', 'NFKBIB']",0.9995105235655231,0,0,21
133,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.3464774440201212,1.2518375482745734,1.3268696353004727,"['NTRK2', 'GABRB1', 'GABRA6', 'PIK3CA', 'GABRA4', 'GABRA3', 'AP2B1', 'AP2A2', 'RHOA']",0.9995105235655231,0,0,9
134,Apoptosis Modulation and Signaling WP1772,0.3475958637049199,1.1518758977305372,1.2172042918989685,"['HRK', 'DFFA', 'TNFRSF6B', 'FOS', 'CFLAR', 'PTPN13', 'NFKB1', 'BBC3', 'CASP9', 'NFKBIA', 'TOLLIP', 'PEA15', 'MADD', 'BIRC6', 'PRKD1', 'BIRC2', 'BCL2L2', 'MAPK3']",0.9995105235655231,0,0,18
135,Glycogen Synthesis and Degradation WP500,0.3479737935393471,1.230460568379743,1.2989087617238926,"['GYS2', 'PPP2CB', 'GSK3A', 'PPP2R2B', 'PHKG2', 'PPP2R5B', 'PHKA1', 'PPP2R5D', 'CALM1', 'CALM2']",0.9995105235655231,0,0,10
136,miRNA regulation of DNA damage response WP1530,0.3492336337202308,1.1705426899274733,1.231427464975456,"['CDKN1B', 'MRE11', 'PRKDC', 'RPA2', 'PML', 'BBC3', 'CASP9', 'CCND2', 'CDK6', 'CCND1', 'RRM2B', 'CCNE2', 'SESN1', 'RAD17', 'ATRIP']",0.9995105235655231,0,0,15
137,Nucleotide Excision Repair WP4753,0.3493998640779062,1.1997418984800687,1.2615745207317464,"['POLE4', 'DDB1', 'POLD4', 'PCNA', 'CETN2', 'POLD2', 'RPA1', 'RPA2', 'RAD23A', 'GTF2H3', 'GTF2H5', 'RBX1']",0.9995105235655231,0,0,12
138,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.3493998640779062,1.1997418984800687,1.2615745207317464,"['NFKBIA', 'DLG1', 'PIK3CA', 'CHP1', 'AHSA1', 'GRB2', 'FOS', 'MAP2K7', 'CALM1', 'CALM2', 'NFKB1', 'MAPK3']",0.9995105235655231,0,0,12
139,Vitamin B12 Disorders WP4271,0.3663746263148435,1.5992562929061784,1.605811484372063,"['MMAB', 'MMACHC', 'CD320']",0.9995105235655231,0,0,3
140,Cori Cycle WP1946,0.3763234775022727,1.421586393260213,1.3893251859365516,"['PGK1', 'TALDO1', 'ALDOA', 'GAPDH']",0.9995105235655231,0,0,4
141,Omega-3/Omega-6 FA synthesis WP4723,0.3763234775022727,1.421586393260213,1.3893251859365516,"['ACOX1', 'ACOT2', 'ACOX3', 'PLA2G6']",0.9995105235655231,0,0,4
142,Acute viral myocarditis WP4298,0.3778159340200515,1.1425701164507134,1.1121185079462008,"['DFFA', 'CXADR', 'PARP1', 'STAT1', 'ILK', 'CASP9', 'CCND1', 'SGCB', 'RASA1', 'DAG1', 'RAC3', 'NOS1', 'EIF4G2', 'MAPK3', 'EIF4G1']",0.9995105235655231,0,0,15
143,Chemokine signaling pathway WP3929,0.3789761471853745,1.0925648755191095,1.0600960457320006,"['ROCK2', 'PXN', 'ADCY3', 'ADCY8', 'CXCL14', 'PRKCZ', 'GNAI2', 'CDC42', 'GNG10', 'GNG3', 'RAP1A', 'GNG4', 'AKT3', 'RAC1', 'MAPK3', 'VAV3', 'STAT1', 'BRAF', 'NFKB1', 'NFKBIA', 'PIK3CA', 'GNB1', 'GNB4', 'GRB2', 'GNB5', 'PLCB1', 'CRK', 'NFKBIB']",0.9995105235655231,0,0,28
144,Constitutive Androstane Receptor Pathway WP2875,0.3811481974870675,1.3327609234878839,1.285537218616706,"['SULT1A1', 'NCOA1', 'NCOA2', 'HSP90AA1', 'DNAJC7']",0.9995105235655231,0,0,5
145,"GPCRs, Class B Secretin-like WP334",0.3811481974870675,1.3327609234878839,1.285537218616706,"['ADCYAP1R1', 'VIPR2', 'ADGRE5', 'ADGRL2', 'ADGRL3']",0.9995105235655231,0,0,5
146,RANKL/RANK signaling pathway WP2018,0.38172299288586575,1.1632817999322158,1.1203102667219207,"['CDC42', 'NFKBIA', 'STAT1', 'TRAF2', 'MITF', 'TAB2', 'RAC1', 'FOS', 'MAP2K7', 'SQSTM1', 'NFKB1', 'MAPK3']",0.9995105235655231,0,0,12
147,Fatty Acid Biosynthesis WP357,0.3835232111370716,1.279473232178643,1.2261897428302757,"['MECR', 'ECHS1', 'ECH1', 'ECHDC1', 'ECHDC2', 'ACACB']",0.9995105235655231,0,0,6
148,Aryl Hydrocarbon Receptor Pathway WP2873,0.3845442054279286,1.2439544355351915,1.1888429350829637,"['NCOA1', 'HSP90AA1', 'CDKN1B', 'PTGES3', 'CDC37', 'AIP', 'JUNB']",0.9995105235655231,0,0,7
149,Oxidative Stress WP408,0.3845442054279286,1.2439544355351915,1.1888429350829637,"['MAPK10', 'NFIX', 'TXNRD2', 'TXNRD1', 'FOS', 'JUNB', 'NFKB1']",0.9995105235655231,0,0,7
150,Androgen receptor signaling pathway WP138,0.39297859516993466,1.1013819888950687,1.0286909250067935,"['NCOA1', 'NCOA2', 'UBE2I', 'ROCK2', 'NCOA3', 'DSTN', 'RNF4', 'RHOA', 'RUNX2', 'RHOB', 'CDC42', 'PSMC3IP', 'CCND1', 'SUMO1', 'ZMIZ1', 'RACK1', 'KAT7', 'RAC1', 'PATZ1', 'PLPP1', 'RAN']",0.9995105235655231,0,0,21
151,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.3974527517419294,1.0788754104952751,0.9954559173725156,"['YWHAE', 'RYR2', 'ADCYAP1R1', 'VIPR2', 'CHRNA4', 'YWHAB', 'ATP1A3', 'YBX1', 'ASCL1', 'HSP90B1', 'HSPD1', 'SOX2', 'MECP2', 'YWHAQ', 'TPPP', 'PRKACA', 'SCN3B', 'YWHAH', 'EGR1', 'NTRK2', 'MBD1', 'SSTR2', 'NFKB1', 'GCK', 'PRKAR1A', 'SST', 'ALDOA', 'GAPDH', 'SLC25A4']",0.9995105235655231,0,0,29
152,Cardiac Hypertrophic Response WP2795,0.4117040794628245,1.123901009443178,0.9974064469555554,"['HDAC5', 'CAMK2D', 'IGF1', 'NFKB1', 'PPP3CA', 'RAC1', 'PRKD1', 'MAP2K7', 'CALM1', 'CALM2', 'PRKG1', 'FGFR2', 'MAPK3']",0.9995105235655231,0,0,13
153,Aflatoxin B1 metabolism WP699,0.4197304560219231,3.19811320754717,2.776418139532309,['AKR7A2'],0.9995105235655231,0,0,1
154,Arylamine metabolism WP694,0.4197304560219231,3.19811320754717,2.776418139532309,['SULT1A1'],0.9995105235655231,0,0,1
155,Corticotropin-releasing hormone signaling pathway WP2355,0.4228986787518695,1.085324302134647,0.9340546865256145,"['NCOA2', 'HSP90AA1', 'PARP1', 'BRAF', 'FOS', 'RHOA', 'NFKB1', 'GNAI2', 'CASP9', 'ERN1', 'NFKBIA', 'GNAO1', 'NR4A1', 'STAR', 'GNB1', 'FOSB', 'GNB5', 'JUNB', 'MAPK3']",0.9995105235655231,0,0,19
156,CAMKK2  Pathway WP4874,0.4254722685570413,1.1630947110752323,0.9939289903625695,"['MAP1LC3A', 'NOS1', 'RAC1', 'CALM1', 'SQSTM1', 'CALM2', 'CAMKK2', 'MAPK3']",0.9995105235655231,0,0,8
157,Endothelin Pathways WP2197,0.4284202802578755,1.1783776451437873,0.9988525202794568,"['EDNRA', 'RIIAD1', 'ATP2A2', 'GNB5', 'PLCB1', 'CALM1', 'CALM2']",0.9995105235655231,0,0,7
158,Resistin as a regulator of inflammation WP4481,0.4284202802578755,1.1783776451437873,0.9988525202794568,"['NFKBIA', 'PIK3CA', 'AKT3', 'ITPR1', 'PLCB1', 'NFKB1', 'MAPK3']",0.9995105235655231,0,0,7
159,Trans-sulfuration and one-carbon metabolism WP2525,0.4284202802578755,1.1783776451437873,0.9988525202794568,"['AHCYL2', 'MTHFD1', 'MTHFD2', 'GSS', 'MTHFD2L', 'AMT', 'MAT2B']",0.9995105235655231,0,0,7
160,Nonalcoholic fatty liver disease WP4396,0.4299223033321702,1.0553465814647085,0.8908716362687118,"['GSK3A', 'NDUFB8', 'NDUFB6', 'NDUFA12', 'NDUFB4', 'PRKAG1', 'NDUFB1', 'ADIPOR1', 'BBC3', 'CDC42', 'AKT3', 'LEPR', 'NDUFV3', 'RAC1', 'NDUFV1', 'NDUFA9', 'NDUFA8', 'PRKAB2', 'NDUFA5', 'NDUFC2', 'SDHC', 'TRAF2', 'EIF2S1', 'NFKB1', 'ERN1', 'COX7A2L', 'PIK3CA', 'NDUFAB1', 'NDUFS3', 'NDUFS1', 'UQCRC2', 'ATF4']",0.9995105235655231,0,0,32
161,1q21.1 copy number variation syndrome WP4905,0.4313893241135956,1.1993987975951903,1.0083876933946607,"['TJP1', 'PYGO2', 'AFDN', 'BCL9', 'PRKAB2', 'PRKAG1']",0.9995105235655231,0,0,6
162,Estrogen signaling pathway WP712,0.4313893241135956,1.1993987975951903,1.0083876933946607,"['PIK3CA', 'GNB1', 'BRAF', 'FOS', 'PRKACA', 'NFKB1']",0.9995105235655231,0,0,6
163,Signal Transduction of S1P Receptor WP26,0.4313893241135956,1.1993987975951903,1.0083876933946607,"['ASAH1', 'AKT3', 'MAPK6', 'PLCB1', 'GNAI2', 'MAPK3']",0.9995105235655231,0,0,6
164,Sphingolipid Metabolism (general overview) WP4725,0.4313893241135956,1.1993987975951903,1.0083876933946607,"['UGCG', 'ASAH1', 'SGPL1', 'DEGS1', 'KDSR', 'SGPP2']",0.9995105235655231,0,0,6
165,Apoptosis WP254,0.4322729462385758,1.0889121019419552,0.9132684785766261,"['HRK', 'DFFA', 'TRAF2', 'IGF1', 'CFLAR', 'NFKB1', 'IGF1R', 'BBC3', 'CASP9', 'NFKBIA', 'MAPK10', 'NFKBIE', 'TNFRSF21', 'BIRC2', 'BCL2L2', 'NFKBIB']",0.9995105235655231,0,0,16
166,Melanoma WP4685,0.4322729462385758,1.0889121019419552,0.9132684785766261,"['MITF', 'BRAF', 'FOS', 'CDK6', 'CCND1', 'PIK3CA', 'CDH1', 'ERBB4', 'AKT3', 'NF1', 'GRB2', 'RAC1', 'CALM1', 'CALM2', 'VCL', 'MAPK3']",0.9995105235655231,0,0,16
167,Hippo-Yap signaling pathway WP4537,0.4343023976932756,1.230130773633922,1.0259465559898762,"['RASSF1', 'YWHAQ', 'TNIK', 'TEAD1', 'MAP4K3']",0.9995105235655231,0,0,5
168,Nucleotide metabolism WP404,0.4343023976932756,1.230130773633922,1.0259465559898762,"['PRPS1', 'RRM1', 'RRM2B', 'MTHFD2', 'SRM']",0.9995105235655231,0,0,5
169,"Relationship between inflammation, COX-2 and EGFR WP4483",0.4343023976932756,1.230130773633922,1.0259465559898762,"['PIK3CA', 'PTGES2', 'AKT3', 'BRAF', 'MAPK3']",0.9995105235655231,0,0,5
170,GDNF/RET signaling axis WP4830,0.4369694363084827,1.27931330472103,1.0591332839005227,"['SOX11', 'SLIT2', 'HSPB11', 'GLI3']",0.9995105235655231,0,0,4
171,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.4369694363084827,1.27931330472103,1.0591332839005227,"['CDH2', 'CDH1', 'RUNX2', 'MAPK3']",0.9995105235655231,0,0,4
172,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.43796263899926885,1.5990849299399486,1.320239172459302,"['ID2', 'RUNX2']",0.9995105235655231,0,0,2
173,Methylation Pathways WP704,0.43796263899926885,1.5990849299399486,1.320239172459302,"['MAT2B', 'HNMT']",0.9995105235655231,0,0,2
174,miRNA Biogenesis WP2338,0.43796263899926885,1.5990849299399486,1.320239172459302,"['XPO5', 'RAN']",0.9995105235655231,0,0,2
175,Molybdenum cofactor (Moco) biosynthesis WP4507,0.43796263899926885,1.5990849299399486,1.320239172459302,"['SUOX', 'MOCS1']",0.9995105235655231,0,0,2
176,Peroxiredoxin 2 induced ovarian failure WP4873,0.43796263899926885,1.5990849299399486,1.320239172459302,"['MAPK10', 'STAR']",0.9995105235655231,0,0,2
177,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.43796263899926885,1.5990849299399486,1.320239172459302,"['NFKBIA', 'NFKB1']",0.9995105235655231,0,0,2
178,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.4388537947025295,1.3706685191238968,1.1288674643608771,"['GABBR1', 'GRM5', 'GRM4']",0.9995105235655231,0,0,3
179,Iron metabolism in placenta WP2007,0.4388537947025295,1.3706685191238968,1.1288674643608771,"['TFR2', 'FTH1', 'MCOLN1']",0.9995105235655231,0,0,3
180,miR-509-3p alteration of YAP1/ECM axis WP3967,0.4388537947025295,1.3706685191238968,1.1288674643608771,"['EDNRA', 'SPARC', 'TEAD1']",0.9995105235655231,0,0,3
181,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.4388537947025295,1.3706685191238968,1.1288674643608771,"['UBE2N', 'UBE2V1', 'NFKB1']",0.9995105235655231,0,0,3
182,TCA cycle in senescence WP5050,0.4388537947025295,1.3706685191238968,1.1288674643608771,"['PDHA1', 'ME1', 'BRAF']",0.9995105235655231,0,0,3
183,IL-1 signaling pathway WP195,0.4429811354382978,1.0942265301808738,0.8909499815311498,"['PTPN11', 'IL1RAP', 'PRKCZ', 'NFKB1', 'NFKBIA', 'TOLLIP', 'UBE2N', 'TAB2', 'UBE2V1', 'MAP2K7', 'SQSTM1', 'MAPK3', 'NFKBIB']",0.9995105235655231,0,0,13
184,Alzheimer's disease WP2059,0.45225090135803975,1.066168725462032,0.8460242470438754,"['MME', 'PSEN2', 'ITPR1', 'ATP2A2', 'ATP2A1', 'HSD17B10', 'CASP9', 'ERN1', 'BACE1', 'PPP3CA', 'CHP1', 'NOS1', 'MAPT', 'PLCB1', 'CALM1', 'GAPDH', 'CALM2', 'MAPK3']",0.9995105235655231,0,0,18
185,IL-18 signaling pathway WP4754,0.46466618657330405,1.0281247415005377,0.7879918241745296,"['MTCH1', 'PIGT', 'TOMM40', 'CD83', 'ANP32A', 'EPB41', 'CD81', 'HSPB8', 'KLC1', 'ACACB', 'ELAVL1', 'CENPB', 'RXRB', 'ADAMTS5', 'STMN1', 'MAP2K7', 'B2M', 'ACADS', 'ABCF1', 'MAPK3', 'MBTPS1', 'PARP1', 'ECH1', 'HPS1', 'FOS', 'BPGM', 'DEK', 'CFLAR', 'EEF2', 'RUNX2', 'NFKB1', 'ARFGAP2', 'NFKBIA', 'SLC4A7', 'NR4A1', 'BMP2', 'NACA', 'SYT10', 'RFX5', 'CLDN12', 'ZNF219', 'HDGF', 'LTB', 'NFKBIE', 'AARS']",0.9995105235655231,0,0,45
186,Alpha 6 Beta 4 signaling pathway WP244,0.465941096530784,1.112425740724596,0.8495551498279995,"['EIF4EBP1', 'GAB1', 'PTPN11', 'GRB2', 'LAMC1', 'RAC1', 'RHOA', 'MAPK3']",0.9995105235655231,0,0,8
187,Neural Crest Cell Migration in Cancer WP4565,0.465941096530784,1.112425740724596,0.8495551498279995,"['NTRK2', 'ARF1', 'TRIO', 'PIK3CA', 'AKT3', 'RAC1', 'FOS', 'RHOA']",0.9995105235655231,0,0,8
188,Pre-implantation embryo WP3527,0.4718734853059348,1.1193585337915235,0.8406879236197539,"['SOX2', 'EGR1', 'CDH1', 'FOSB', 'SOX11', 'ATP1A1', 'ELAVL1']",0.9995105235655231,0,0,7
189,16p11.2 distal deletion syndrome WP4950,0.47857941080633537,1.1287448847274382,0.8318094941696308,"['CD81', 'PRMT1', 'ATP2A1', 'TRAF2', 'GRB2', 'SH2B1']",0.9995105235655231,0,0,6
190,Fluoropyrimidine Activity WP1601,0.47857941080633537,1.1287448847274382,0.8318094941696308,"['ABCC4', 'RRM1', 'UCK2', 'GGH', 'UMPS', 'CES2']",0.9995105235655231,0,0,6
191,Sphingolipid Metabolism (integrated pathway) WP4726,0.47857941080633537,1.1287448847274382,0.8318094941696308,"['UGCG', 'ASAH1', 'SGPL1', 'DEGS1', 'KDSR', 'SGPP2']",0.9995105235655231,0,0,6
192,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.48636538360040454,1.1421620737590972,0.823264848383568,"['PDHA1', 'PRKAG1', 'KEAP1', 'PDHB', 'ACACB']",0.9995105235655231,0,0,5
193,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.48636538360040454,1.1421620737590972,0.823264848383568,"['BECN1', 'MAP1LC3A', 'ATG16L1', 'ULK2', 'WIPI1']",0.9995105235655231,0,0,5
194,Kallmann's Syndrome WP5074,0.48636538360040454,1.1421620737590972,0.823264848383568,"['PIK3CA', 'PTPN11', 'GRB2', 'ASCL1', 'FGFR1']",0.9995105235655231,0,0,5
195,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.48814725861674485,1.0442792103921672,0.7488924706196428,"['MBTPS1', 'GSK3A', 'SEC13', 'PRKAB2', 'SEC24B', 'SAR1A', 'NR1H2', 'PRKAG1', 'CDK8', 'RBP4', 'PIK3CA', 'PPARG', 'PRKACA', 'SEC23B', 'KPNB1', 'SEC31A']",0.9995105235655231,0,0,16
196,Regulation of Microtubule Cytoskeleton WP2038,0.4912974998605371,1.06601700582784,0.7576240730696857,"['CDC42', 'TRIO', 'PIK3CA', 'PTPRA', 'DPYSL2', 'STMN1', 'TPPP', 'RAC1', 'MAPT', 'PRKACA']",0.9995105235655231,0,0,10
197,Pathways Regulating Hippo Signaling WP4540,0.49465962112381906,1.031627553338464,0.7261475596581317,"['NTRK2', 'PRKAB2', 'FLT1', 'PRKAG1', 'PRKCZ', 'RHOA', 'IGF1R', 'GNAI2', 'CDC42', 'GNAL', 'CDH2', 'CDH1', 'PRKAR1A', 'RAC1', 'PRKACA', 'PLCB1', 'TEAD1', 'FGFR2', 'CDH18', 'FGFR1']",0.9995105235655231,0,0,20
198,G13 Signaling Pathway WP524,0.4981307140655955,1.0659980897803247,0.7428863491886561,"['CDC42', 'MAPK10', 'PIK3CA', 'ROCK2', 'RAC1', 'CALM1', 'CALM2', 'RHOA', 'CIT']",0.9995105235655231,0,0,9
199,Hepatitis C and Hepatocellular Carcinoma WP3646,0.4981307140655955,1.0659980897803247,0.7428863491886561,"['CASP9', 'UCHL1', 'CCND1', 'COL4A2', 'PTPN11', 'GRB2', 'RAC1', 'NFKB1', 'MAPK3']",0.9995105235655231,0,0,9
200,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.5078724587858965,1.1992276887871853,0.8125066538704319,"['BMP2', 'SMURF1', 'RUNX2']",0.9995105235655231,0,0,3
201,Ganglio Sphingolipid Metabolism WP1423,0.5078724587858965,1.1992276887871853,0.8125066538704319,"['ST8SIA1', 'ST8SIA3', 'ST3GAL5']",0.9995105235655231,0,0,3
202,Serotonin and anxiety-related events WP3944,0.5078724587858965,1.1992276887871853,0.8125066538704319,"['PPP3CA', 'ARC', 'FOS']",0.9995105235655231,0,0,3
203,Leptin signaling pathway WP2034,0.5100215591023504,1.025733421477572,0.6906286527967971,"['NCOA1', 'KHDRBS1', 'GSK3A', 'ROCK2', 'STAT1', 'PTPN11', 'ACACB', 'RHOA', 'NFKB1', 'CDC42', 'CCND1', 'LEPR', 'EIF4EBP1', 'GRB2', 'RAC1', 'MAPK3', 'SH2B1']",0.9995105235655231,0,0,17
204,Interferon type I signaling pathways WP585,0.5114832280759164,1.0371495671180213,0.6953470575655188,"['EIF4A1', 'RAP1A', 'PRMT1', 'STAT1', 'RACK1', 'EIF4EBP1', 'PTPN11', 'RAC1', 'CRK', 'IRF9', 'EIF4B', 'IFNAR1']",0.9995105235655231,0,0,12
205,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5144340818240254,1.0659602901870944,0.7085308564157077,"['NFKBIA', 'STAT1', 'EIF2AK2', 'FOS', 'NFKB1', 'IRF9', 'IFNAR1']",0.9995105235655231,0,0,7
206,Neural Crest Cell Migration during Development WP4564,0.5144340818240254,1.0659602901870944,0.7085308564157077,"['ARF1', 'TRIO', 'PIK3CA', 'AKT3', 'RAC1', 'FOS', 'RHOA']",0.9995105235655231,0,0,7
207,Aspirin and miRNAs WP4707,0.5253357862476983,1.2791535601944524,0.8234136956034522,"['ABCC4', 'NFKB1']",0.9995105235655231,0,0,2
208,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.5253357862476983,1.2791535601944524,0.8234136956034522,"['MRE11', 'DDX1']",0.9995105235655231,0,0,2
209,Estrogen metabolism WP697,0.5253357862476983,1.2791535601944524,0.8234136956034522,"['SULT1A1', 'ARSD']",0.9995105235655231,0,0,2
210,LDLRAD4 and what we know about it WP4904,0.5253357862476983,1.2791535601944524,0.8234136956034522,"['ATG16L1', 'LDLRAD4']",0.9995105235655231,0,0,2
211,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.5253357862476983,1.2791535601944524,0.8234136956034522,"['MAT2B', 'CDO1']",0.9995105235655231,0,0,2
212,NAD Biosynthesis II (from tryptophan) WP2485,0.5253357862476983,1.2791535601944524,0.8234136956034522,"['QPRT', 'KMO']",0.9995105235655231,0,0,2
213,Serotonin Transporter Activity WP1455,0.5253357862476983,1.2791535601944524,0.8234136956034522,"['PPP2CB', 'NOS1']",0.9995105235655231,0,0,2
214,Sulfation Biotransformation Reaction WP692,0.5253357862476983,1.2791535601944524,0.8234136956034522,"['SULT1A1', 'SULT4A1']",0.9995105235655231,0,0,2
215,Supression of HMGB1 mediated inflammation by THBD WP4479,0.5253357862476983,1.2791535601944524,0.8234136956034522,"['NFKBIA', 'NFKB1']",0.9995105235655231,0,0,2
216,Type III interferon signaling WP2113,0.5253357862476983,1.2791535601944524,0.8234136956034522,"['STAT1', 'IRF9']",0.9995105235655231,0,0,2
217,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.5310109254360639,0.9980284738709867,0.6317247605597263,"['CDKN1B', 'CHRM1', 'FLT1', 'HSP90AB1', 'CAB39L', 'SLC2A3', 'ITGAE', 'LAMC1', 'FGF1', 'ELAVL1', 'IGF1R', 'GYS2', 'GHR', 'CASP9', 'AKT3', 'NOS1', 'RAB2A', 'HSP90AA1', 'PPP2R5B', 'PPP2R5D', 'CREB3', 'COL4A2', 'PIK3CA', 'COL4A1', 'CDC37', 'EIF4E2', 'ATF4', 'IFNAR1', 'LPAR1', 'PDGFA', 'EFNA5', 'HSP90B1', 'PPP2CB', 'GNG10', 'GNG3', 'RELN', 'GNG4', 'PPP2R3C', 'PDGFC', 'EIF4EBP1', 'FGF22', 'EIF4B', 'MAPK3', 'IGF1', 'RAB14', 'PIK3IP1', 'PPP2R2B', 'ITGA10', 'GNB1', 'GNB4', 'GRB2', 'FGF12', 'FGFR2', 'FGFR1']",0.9995105235655231,0,0,54
218,Monoamine Transport WP727,0.5366030153198488,1.0659225338675826,0.6635332829186604,"['PPP2CB', 'AMPH', 'NOS1', 'SLC6A1', 'NECTIN2']",0.9995105235655231,0,0,5
219,Striated Muscle Contraction Pathway WP383,0.5366030153198488,1.0659225338675826,0.6635332829186604,"['TPM4', 'TPM3', 'TPM1', 'ACTG1', 'TTN']",0.9995105235655231,0,0,5
220,PI3K-Akt signaling pathway WP4172,0.5392733267795332,0.9946880950075838,0.6142524616005431,"['CDKN1B', 'CHRM1', 'FLT1', 'HSP90AB1', 'LAMC1', 'FGF1', 'IGF1R', 'GYS2', 'GHR', 'CASP9', 'CCND2', 'CCND1', 'AKT3', 'RAC1', 'HSP90AA1', 'PPP2R5B', 'PPP2R5D', 'CREB3', 'COL4A2', 'CCNE2', 'PIK3CA', 'COL4A1', 'CDC37', 'SGK3', 'EIF4E2', 'SGK2', 'ATF4', 'IFNAR1', 'LPAR1', 'PDGFA', 'EFNA5', 'HSP90B1', 'PPP2CB', 'GNG10', 'GNG3', 'RELN', 'GNG4', 'PPP2R3C', 'PDGFC', 'EIF4EBP1', 'FGF22', 'EIF4B', 'MAPK3', 'NTRK2', 'IGF1', 'NFKB1', 'CDK6', 'PPP2R2B', 'ITGA10', 'GNB1', 'GNB4', 'GRB2', 'GNB5', 'FGF12', 'FGFR2', 'FGFR1']",0.9995105235655231,0,0,56
221,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5429526016005588,1.0031469377874607,0.6126551922793108,"['RALB', 'DCC', 'BRAF', 'FOS', 'RHOA', 'BBC3', 'CASP9', 'MAPK10', 'CCND1', 'MSH2', 'AKT3', 'RAC3', 'RAC1', 'RALGDS', 'EXOC2', 'MAPK3']",0.9995105235655231,0,0,16
222,Head and Neck Squamous Cell Carcinoma WP4674,0.5429526016005588,1.0031469377874607,0.6126551922793108,"['GAB1', 'KEAP1', 'NFKB1', 'IGF1R', 'CDK6', 'CCND1', 'PIK3CA', 'SESN1', 'SESN2', 'AKT3', 'EIF4EBP1', 'FAT1', 'RICTOR', 'BIRC2', 'FGFR2', 'FGFR1']",0.9995105235655231,0,0,16
223,Oxidative Damage WP3941,0.5445914830429816,1.0232483529074763,0.6218478114205144,"['CDC42', 'CASP9', 'MAPK10', 'PCNA', 'CDKN1B', 'TRAF2', 'NFKBIE', 'NFKB1']",0.9995105235655231,0,0,8
224,p38 MAPK Signaling Pathway WP400,0.5445914830429816,1.0232483529074763,0.6218478114205144,"['CDC42', 'STAT1', 'RASGRF1', 'TRAF2', 'GRB2', 'RAC1', 'MEF2D', 'HMGN1']",0.9995105235655231,0,0,8
225,Parkinson's disease pathway WP2371,0.5445914830429816,1.0232483529074763,0.6218478114205144,"['CASP9', 'UCHL1', 'UBB', 'CCNE2', 'SYT11', 'UBE2L6', 'UBE2G2', 'UBE2J2']",0.9995105235655231,0,0,8
226,Kynurenine Pathway and links to Cellular Senescence WP5044,0.5517624224334607,1.0659036719122557,0.633826528665615,"['EIF2AK1', 'QPRT', 'NOS1', 'KMO']",0.9995105235655231,0,0,4
227,miRNA targets in ECM and membrane receptors WP2911,0.5517624224334607,1.0659036719122557,0.633826528665615,"['COL4A2', 'COL4A1', 'SDC2', 'LAMC1']",0.9995105235655231,0,0,4
228,Melatonin metabolism and effects WP3298,0.5556984505109651,1.017416432364886,0.5977621546291166,"['SULT1A1', 'CRY2', 'CRY1', 'CSNK1E', 'CALM1', 'CALM2', 'NFKB1']",0.9995105235655231,0,0,7
229,Nuclear receptors WP170,0.5556984505109651,1.017416432364886,0.5977621546291166,"['RXRB', 'NR4A1', 'THRA', 'NR1H2', 'ROR1', 'PPARG', 'NR2F6']",0.9995105235655231,0,0,7
230,PDGFR-beta pathway WP3972,0.5556984505109651,1.017416432364886,0.5977621546291166,"['PIK3CA', 'STAT1', 'RASA1', 'EIF2AK2', 'GRB2', 'FOS', 'MAPK3']",0.9995105235655231,0,0,7
231,Prion disease pathway WP3995,0.5556984505109651,1.017416432364886,0.5977621546291166,"['PDIA3', 'HSPA5', 'RFX5', 'NFKB1', 'HSP90B1', 'MAPK3', 'FGFR1']",0.9995105235655231,0,0,7
232,Tumor suppressor activity of SMARCB1 WP4204,0.5556984505109651,1.017416432364886,0.5977621546291166,"['SMARCD1', 'CDK6', 'RBBP4', 'DPF2', 'ARID1A', 'ARID1B', 'GLI3']",0.9995105235655231,0,0,7
233,GABA metabolism (aka GHB) WP4157,0.5579912543698338,1.5989136649514009,0.9328254029411911,['AKR7A2'],0.9995105235655231,0,0,1
234,Gastric acid production WP2596,0.5579912543698338,1.5989136649514009,0.9328254029411911,['CCK'],0.9995105235655231,0,0,1
235,Steroid Biosynthesis WP496,0.5579912543698338,1.5989136649514009,0.9328254029411911,['HSD17B1'],0.9995105235655231,0,0,1
236,ATM Signaling Network in Development and Disease  WP3878,0.5604445524345967,0.9992118085411292,0.5785685840138279,"['MRE11', 'DCLRE1C', 'ATMIN', 'PRKDC', 'RASGRF1', 'RNF8', 'RBBP8', 'NFKB1', 'RNF40', 'HMGN1']",0.9995105235655231,0,0,10
237,IL-6 signaling pathway WP364,0.5706334986695815,0.992303132101571,0.5566901286295713,"['NCOA1', 'STAT1', 'GAB1', 'PTPN11', 'GRB2', 'RAC1', 'JUNB', 'MAPK3', 'NR2F6']",0.9995105235655231,0,0,9
238,Ebola Virus Pathway on Host WP4217,0.572033247418904,0.980433448408132,0.5476291072918561,"['STAT1', 'VPS33A', 'CLTC', 'VPS4A', 'HLA-C', 'EIF2AK2', 'CLTA', 'HLA-A', 'HLA-F', 'EIF2S1', 'NFKB1', 'ASGR1', 'RHOA', 'IGF1R', 'ACTG1', 'RHOB', 'CDC42', 'PIK3CA', 'CTSL', 'VPS41', 'RAC1', 'CTSB', 'MAPK3']",0.9995105235655231,0,0,23
239,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.5721339480553242,1.065884820747521,0.5951710473038943,"['SFRP1', 'BMP2', 'SST']",0.9995105235655231,0,0,3
240,Galanin receptor pathway WP4970,0.5721339480553242,1.065884820747521,0.5951710473038943,"['CDKN1B', 'PPARG', 'FOS']",0.9995105235655231,0,0,3
241,IL1 and megakaryocytes in obesity WP2865,0.5721339480553242,1.065884820747521,0.5951710473038943,"['PIK3CA', 'TIMP2', 'NFKB1']",0.9995105235655231,0,0,3
242,Ciliopathies WP4803,0.5787981648082696,0.9775054786083619,0.5345014178890117,"['GALNT11', 'C2CD3', 'ARL6', 'ARL3', 'PKD1L1', 'CCDC28B', 'GLI3', 'DYNC2LI1', 'TCTN3', 'CSPP1', 'TTC21B', 'TCTEX1D2', 'TMEM107', 'TCTN1', 'BBS9', 'RAB28', 'IFT57', 'DNAI1', 'BBS4', 'DYNC2H1', 'MKKS', 'DNAAF1', 'WDR19', 'LCA5', 'CFAP410', 'KIF7', 'POMGNT1', 'TTLL5', 'RSPH1', 'TMEM17', 'IFT43', 'TMEM138', 'NME7', 'CEP83', 'CEP41', 'CLUAP1', 'TRIM32']",0.9995105235655231,0,0,37
243,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.5844404236477089,0.9992129364625072,0.5366776981358368,"['TGFBR3', 'RUNX2', 'MAPK3', 'FBN1', 'ENG']",0.9995105235655231,0,0,5
244,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.5844404236477089,0.9992129364625072,0.5366776981358368,"['BMP2', 'OMG', 'IGF1', 'ASCL1', 'SOX6']",0.9995105235655231,0,0,5
245,DNA IR-damage and cellular response via ATR WP4016,0.5880504803722557,0.9705218675637974,0.5152912909419467,"['UPF1', 'FEN1', 'MRE11', 'PCNA', 'PARP1', 'PRKDC', 'XRCC5', 'RPA1', 'HUS1', 'RPA2', 'PML', 'MSH2', 'RBBP8', 'USP1', 'RAD17', 'ATRIP', 'MCPH1']",0.9995105235655231,0,0,17
246,NRF2 pathway WP2884,0.6002249545803988,0.9633954637323153,0.491765956018361,"['GSTM3', 'EGR1', 'ABCC4', 'HSP90AA1', 'HSP90AB1', 'MGST3', 'SLC2A13', 'TXNRD1', 'KEAP1', 'SLC2A3', 'TXN', 'SLC6A1', 'SLC5A3', 'CES4A', 'SLC39A9', 'FTH1', 'ME1', 'BLVRB', 'SLC39A7', 'SLC39A1', 'SQSTM1', 'CES2']",0.9995105235655231,0,0,22
247,Autosomal recessive Osteopetrosis pathways WP4788,0.6029885615763435,1.0658659803641217,0.5391758222579333,"['OSTM1', 'NFKB1']",0.9995105235655231,0,0,2
248,Bile acids synthesis and enterohepatic circulation  WP4389,0.6029885615763435,1.0658659803641217,0.5391758222579333,"['ABCG8', 'MAPK3']",0.9995105235655231,0,0,2
249,Caloric restriction and aging WP4191,0.6029885615763435,1.0658659803641217,0.5391758222579333,"['PRKAB2', 'IGF1']",0.9995105235655231,0,0,2
250,Cell Differentiation - Index WP2029,0.6029885615763435,1.0658659803641217,0.5391758222579333,"['HDAC5', 'MEF2D']",0.9995105235655231,0,0,2
251,HIF1A and PPARG regulation of glycolysis WP2456,0.6029885615763435,1.0658659803641217,0.5391758222579333,"['PPARG', 'GAPDH']",0.9995105235655231,0,0,2
252,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.6029885615763435,1.0658659803641217,0.5391758222579333,"['STAT1', 'BLVRB']",0.9995105235655231,0,0,2
253,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.6029885615763435,1.0658659803641217,0.5391758222579333,"['RASGRF1', 'NFKB1']",0.9995105235655231,0,0,2
254,Proteoglycan biosynthesis WP4784,0.604259070155072,0.9838230439088809,0.49560307089972777,"['CSGALNACT1', 'CANT1', 'B3GAT3', 'B4GALT7']",0.9995105235655231,0,0,4
255,Common Pathways Underlying Drug Addiction WP2636,0.6051141450486013,0.9591404011461319,0.4818128331609769,"['GRM5', 'RAP1A', 'ADCY8', 'PRKACA', 'CALM1', 'CALM2', 'ACTG1', 'MAPK3', 'GRIA4']",0.9995105235655231,0,0,9
256,EGF/EGFR signaling pathway WP437,0.6055103753454624,0.9644023253961933,0.483824812096459,"['RALB', 'PCNA', 'STXBP1', 'PEBP1', 'CBLB', 'NEDD8', 'ASAP1', 'PRKCZ', 'CDC42', 'RAP1A', 'STMN1', 'EIF4EBP1', 'AP2S1', 'RICTOR', 'RAC1', 'RALGDS', 'MEF2D', 'SH3GL2', 'VAV3', 'RALBP1', 'IQSEC1', 'STAT1', 'NCOA3', 'GAB1', 'BRAF', 'PTPN11', 'FOS', 'PTPN12', 'AP2B1', 'EPN1', 'RASA1', 'FOSB', 'GRB2', 'CRK', 'PTPN5']",0.9995105235655231,0,0,35
257,Lipid Metabolism Pathway WP3965,0.6108043967032716,0.9591754938448325,0.4728529032841829,"['PRKAB2', 'PDHA1', 'PRKAR1A', 'AKT3', 'PRKAG1', 'PRKACA']",0.9995105235655231,0,0,6
258,One-carbon metabolism WP241,0.6108043967032716,0.9591754938448325,0.4728529032841829,"['AHCYL2', 'ATIC', 'MTHFD1', 'MTHFD2', 'AMT', 'MAT2B']",0.9995105235655231,0,0,6
259,Oxysterols derived from cholesterol WP4545,0.6108043967032716,0.9591754938448325,0.4728529032841829,"['DBP', 'NR1H2', 'ACOT2', 'ACOT13', 'SLC27A2', 'SLC27A5']",0.9995105235655231,0,0,6
260,Tryptophan metabolism WP465,0.6108043967032716,0.9591754938448325,0.4728529032841829,"['ALDH3A2', 'GCDH', 'ECHS1', 'WARS', 'PRMT1', 'HSD17B10']",0.9995105235655231,0,0,6
261,Osteoblast differentiation WP4787,0.6138606460375736,0.9542114091800269,0.4656430849257496,"['WNT10B', 'JAG1', 'PRKDC', 'STAT1', 'WNT8A', 'FGF1', 'PRKCZ', 'DLL1', 'RUNX2', 'GLI3', 'DLL3', 'MAPK10', 'BMP2', 'PIK3CA', 'PPARG', 'PRKD1', 'MAPK6', 'FGFR2', 'FGFR1', 'MAPK3']",0.9995105235655231,0,0,20
262,Regulation of toll-like receptor signaling pathway WP1449,0.6138606460375736,0.9542114091800269,0.4656430849257496,"['OTUD5', 'CUEDC2', 'STAT1', 'PELI3', 'TRAFD1', 'FOS', 'NFKB1', 'RNF41', 'NFKBIA', 'MAPK10', 'PIK3CA', 'TOLLIP', 'AKT3', 'TAB2', 'RAC1', 'MAP2K7', 'SQSTM1', 'CTNNAL1', 'IFNAR1', 'MAPK3']",0.9995105235655231,0,0,20
263,PPAR signaling pathway WP3942,0.6140319492430496,0.950447867592363,0.4635413304613742,"['RXRB', 'ACADL', 'FABP5', 'ACOX1', 'ME1', 'ILK', 'APOA1', 'PPARG', 'ACOX3', 'SLC27A2', 'SLC27A5']",0.9995105235655231,0,0,11
264,Pancreatic adenocarcinoma pathway WP4263,0.6211997400209983,0.9489762931034482,0.45181008638625747,"['RALBP1', 'RALB', 'STAT1', 'PEBP1', 'BRAF', 'RHOA', 'NFKB1', 'CASP9', 'CDC42', 'MAPK10', 'CDK6', 'CCND1', 'PIK3CA', 'AKT3', 'RAC3', 'RAC1', 'RALGDS', 'ARHGEF6', 'MAPK3']",0.9995105235655231,0,0,19
265,7-oxo-C and 7beta-HC pathways WP5064,0.6294554196808108,0.9403515269874406,0.43528895375400595,"['DBP', 'ACOT2', 'ACOT13', 'SLC27A2', 'SLC27A5']",0.9995105235655231,0,0,5
266,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.6294554196808108,0.9403515269874406,0.43528895375400595,"['TTC9', 'PNCK', 'CCND1', 'ERBB4', 'TPM3']",0.9995105235655231,0,0,5
267,Nanoparticle triggered autophagic cell death WP2509,0.6294554196808108,0.9403515269874406,0.43528895375400595,"['BECN1', 'MAP1LC3A', 'ATG16L1', 'ATG9B', 'ULK2']",0.9995105235655231,0,0,5
268,SARS-CoV-2 mitochondrial interactions WP5038,0.6294554196808108,0.9403515269874406,0.43528895375400595,"['TOMM70', 'NLRX1', 'CTSL', 'ACAD9', 'NFKB1']",0.9995105235655231,0,0,5
269,Matrix Metalloproteinases WP129,0.6308770425070811,0.9592105263157895,0.44185485832883675,"['MMP16', 'MMP28', 'TIMP2']",0.9995105235655231,0,0,3
270,miRNAs involved in DNA damage response WP1545,0.6308770425070811,0.9592105263157895,0.44185485832883675,"['CDKN1B', 'CDK6', 'CCND1']",0.9995105235655231,0,0,3
271,Phytochemical activity on NRF2 transcriptional activation WP3,0.6308770425070811,0.9592105263157895,0.44185485832883675,"['AIMP2', 'PIK3CA', 'KEAP1']",0.9995105235655231,0,0,3
272,Toll-like Receptor Signaling Pathway WP75,0.6393028319966043,0.9323290291726447,0.41710258401683914,"['STAT1', 'FOS', 'NFKB1', 'NFKBIA', 'MAPK10', 'PIK3CA', 'TOLLIP', 'AKT3', 'TAB2', 'RAC1', 'MAP2K7', 'IFNAR1', 'NFKBIB', 'MAPK3']",0.9995105235655231,0,0,14
273,IL17 signaling pathway WP2112,0.6504989122202867,0.9134186740828596,0.39278432782822775,"['CEBPD', 'PIK3CA', 'IL17RE', 'NFKB1', 'MAPK3', 'NFKBIB']",0.9995105235655231,0,0,6
274,Hedgehog Signaling Pathway WP4249,0.6524368200587112,0.9133690714899537,0.39004601605604206,"['CCND2', 'CCND1', 'SMURF1', 'FBXL17', 'CSNK1E', 'PRKACA', 'KIF7', 'GLI3']",0.9995105235655231,0,0,8
275,NO/cGMP/PKG mediated Neuroprotection WP4008,0.6524368200587112,0.9133690714899537,0.39004601605604206,"['CASP9', 'NFKBIA', 'CAMK2D', 'PRKG2', 'NOS1', 'CALM1', 'CALM2', 'NFKB1']",0.9995105235655231,0,0,8
276,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.6528180793079331,0.9134682199059881,0.389554716330547,"['MDH2', 'IDH2', 'IDH3B', 'SDHC']",0.9995105235655231,0,0,4
277,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.6528180793079331,0.9134682199059881,0.389554716330547,"['STAT1', 'EIF2AK2', 'IRF9', 'IFNAR1']",0.9995105235655231,0,0,4
278,Vitamin D in inflammatory diseases WP4482,0.6528180793079331,0.9134682199059881,0.389554716330547,"['NFKBIA', 'PPP3CA', 'DUSP1', 'NFKB1']",0.9995105235655231,0,0,4
279,Energy Metabolism WP1541,0.6560058304554763,0.9133194120296442,0.38504231431059843,"['NCOA1', 'PPP3CA', 'PRKAB2', 'MYBBP1A', 'PRMT1', 'PRKAG1', 'TFAM', 'PPARG', 'TFB2M', 'MEF2D']",0.9995105235655231,0,0,10
280,Prader-Willi and Angelman Syndrome WP3998,0.6560058304554763,0.9133194120296442,0.38504231431059843,"['CCND2', 'CDK6', 'CCND1', 'FEZ1', 'FEZ2', 'NDN', 'MKRN3', 'ATP10A', 'PRKCZ', 'BBS4']",0.9995105235655231,0,0,10
281,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.6560058304554763,0.9133194120296442,0.38504231431059843,"['NFKBIA', 'MAPK10', 'TOLLIP', 'TAB2', 'IL1RAP', 'FOS', 'MAP2K7', 'NFKB1', 'MAPK3', 'NFKBIB']",0.9995105235655231,0,0,10
282,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.6633157584263143,1.0658471507528111,0.4375346734456047,['NFKB1'],0.9995105235655231,0,0,1
283,Composition of Lipid Particles WP3601,0.6633157584263143,1.0658471507528111,0.4375346734456047,['APOA1'],0.9995105235655231,0,0,1
284,Effects of nitric oxide WP1995,0.6633157584263143,1.0658471507528111,0.4375346734456047,['NOS1'],0.9995105235655231,0,0,1
285,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.6633157584263143,1.0658471507528111,0.4375346734456047,['GSS'],0.9995105235655231,0,0,1
286,Hypothetical Craniofacial Development Pathway WP3655,0.6633157584263143,1.0658471507528111,0.4375346734456047,['RHOA'],0.9995105235655231,0,0,1
287,Macrophage markers WP4146,0.6633157584263143,1.0658471507528111,0.4375346734456047,['CD83'],0.9995105235655231,0,0,1
288,Sulindac Metabolic Pathway WP2542,0.6633157584263143,1.0658471507528111,0.4375346734456047,['MSRB2'],0.9995105235655231,0,0,1
289,Neural Crest Differentiation WP2064,0.6648661691651466,0.9132199221151875,0.3727485262648022,"['HDAC5', 'HDAC11', 'WNT8A', 'MITF', 'ASCL1', 'DLL1', 'NFKB1', 'RHOB', 'DLL3', 'CDH2', 'CDH1', 'MPZ', 'FGFR2', 'FGFR1']",0.9995105235655231,0,0,14
290,IL-2 signaling pathway WP49,0.6687181872279773,0.895085910652921,0.3601759042081777,"['CCND2', 'STAT1', 'PTPN11', 'GRB2', 'FOS', 'MAPT', 'MAPK3']",0.9995105235655231,0,0,7
291,Mitochondrial CIV Assembly WP4922,0.6687181872279773,0.895085910652921,0.3601759042081777,"['TMEM177', 'SURF1', 'COX16', 'COX15', 'COX11', 'SMIM20', 'PET117']",0.9995105235655231,0,0,7
292,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.6695673772060184,0.9131700914646651,0.3662939656667126,"['HDAC5', 'CAMK2D', 'ROCK2', 'IGF1', 'RHOA', 'NFKB1', 'IGF1R', 'PPP3CA', 'PIK3CA', 'RAC1', 'MAP2K7', 'CALM1', 'CALM2', 'PRKG1', 'FGFR2', 'MAPK3']",0.9995105235655231,0,0,16
293,Retinoblastoma gene in cancer WP2446,0.6695673772060184,0.9131700914646651,0.3662939656667126,"['RRM1', 'CDKN1B', 'PCNA', 'PRMT2', 'PRKDC', 'HMGB2', 'RPA1', 'RPA2', 'RABIF', 'CDK6', 'CCND1', 'CCNE2', 'RBBP4', 'STMN1', 'MCM4', 'MCM6']",0.9995105235655231,0,0,16
294,Biotin Metabolism (including IEMs) WP5031,0.6705924792430431,0.9135177090567426,0.36503588481855265,"['PCCB', 'ACACB']",0.9995105235655231,0,0,2
295,Cytosine methylation WP3585,0.6705924792430431,0.9135177090567426,0.36503588481855265,"['MECP2', 'IDH2']",0.9995105235655231,0,0,2
296,EDA signaling in hair follicle development WP3930,0.6705924792430431,0.9135177090567426,0.36503588481855265,"['BMP1', 'LTB']",0.9995105235655231,0,0,2
297,Osteoclast Signaling WP12,0.6705924792430431,0.9135177090567426,0.36503588481855265,"['AIMP2', 'IFNAR1']",0.9995105235655231,0,0,2
298,IL-9 signaling pathway WP22,0.683760884827286,0.8719315581443728,0.3314621713213123,"['STAT1', 'GRB2', 'MAPK3']",0.9995105235655231,0,0,3
299,NAD+ metabolism WP3644,0.683760884827286,0.8719315581443728,0.3314621713213123,"['NT5E', 'PARP1', 'SIRT6']",0.9995105235655231,0,0,3
300,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.683760884827286,0.8719315581443728,0.3314621713213123,"['PDHA1', 'PIK3CA', 'SLC2A3']",0.9995105235655231,0,0,3
301,Serotonin and anxiety WP3947,0.683760884827286,0.8719315581443728,0.3314621713213123,"['PPP3CA', 'ARC', 'FOS']",0.9995105235655231,0,0,3
302,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.6848612033397171,0.8817945653354933,0.3337937071374107,"['MAPK10', 'YWHAQ', 'CDH1', 'LIMD1', 'MAP4K5', 'TEAD1', 'MAP4K3', 'ACTG1']",0.9995105235655231,0,0,8
303,Oncostatin M Signaling Pathway WP2374,0.6868303281128783,0.8919508339947045,0.3350773790848942,"['NFKBIA', 'EGR1', 'CDKN1B', 'STAT1', 'PXN', 'RICTOR', 'PTPN11', 'GRB2', 'FOS', 'JUNB', 'NFKB1', 'MAPK3']",0.9995105235655231,0,0,12
304,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6876074698716548,0.8718215652083388,0.32652955723175936,"['CASP9', 'NFKBIA', 'HSP90AA1', 'COPS6', 'RAC1', 'AAMP']",0.9995105235655231,0,0,6
305,Mitochondrial Gene Expression WP391,0.697205422085425,0.8524940391034812,0.30747344818263256,"['PPP3CA', 'TFAM', 'TFB2M', 'HCFC1']",0.9995105235655231,0,0,4
306,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.697205422085425,0.8524940391034812,0.30747344818263256,"['EGR1', 'RAP1A', 'BRAF', 'MAPK3']",0.9995105235655231,0,0,4
307,Triacylglyceride synthesis WP325,0.697205422085425,0.8524940391034812,0.30747344818263256,"['AGPAT5', 'DGAT2', 'AGPAT1', 'PLPP1']",0.9995105235655231,0,0,4
308,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7021368853322381,0.8605824301700591,0.30432509750415326,"['NFKBIA', 'PIK3CA', 'STAT1', 'EIF4EBP1', 'PTPN11', 'NFKB1', 'MAPK3']",0.9995105235655231,0,0,7
309,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.7021368853322381,0.8605824301700591,0.30432509750415326,"['NFKBIA', 'TRAF2', 'RAC1', 'NFKB1', 'BIRC2', 'MAPK3', 'NFKBIB']",0.9995105235655231,0,0,7
310,Amino Acid metabolism WP3925,0.7023384560761358,0.8877088914402347,0.31366293540593576,"['WARS', 'PDHA1', 'PPM1L', 'MDH2', 'GSS', 'GOT2', 'PYCR1', 'HNMT', 'ADH5', 'GLS', 'SRM', 'RARS', 'SMS', 'IARS', 'BCAT1']",0.9995105235655231,0,0,15
311,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7023384560761358,0.8877088914402347,0.31366293540593576,"['WNT10B', 'CSNK2A1', 'CTNNBIP1', 'CSNK1E', 'SENP2', 'NKD1', 'CDK8', 'SFRP1', 'CCND2', 'FRAT2', 'CDK6', 'HNRNPK', 'CCND1', 'CSNK2B', 'ROR1']",0.9995105235655231,0,0,15
312,Metapathway biotransformation Phase I and II WP702,0.7028488556291282,0.9012337485158883,0.3177871047234763,"['GSTM3', 'GAL3ST1', 'CHST7', 'GSTO1', 'NAA20', 'MGST3', 'GSS', 'AKR1A1', 'HNMT', 'NAT14', 'HS6ST2', 'HS2ST1', 'SULT1A1', 'GSTZ1', 'CYP4Z1', 'AKR7A2', 'NDST3', 'CHST10', 'CYP20A1', 'CHST1', 'NAT9', 'SULT4A1']",0.9995105235655231,0,0,22
313,Vitamin D Receptor Pathway WP2877,0.7076516919122073,0.8928329952670724,0.3087445665743792,"['CDKN2D', 'CDKN1B', 'IGFBP3', 'TPM1', 'MED9', 'G0S2', 'GXYLT2', 'EFNA5', 'ADAMTS5', 'SFRP1', 'CEACAM1', 'CCND1', 'ADGRE5', 'PNOC', 'CREG2', 'TIMP2', 'CLPTM1L', 'JUNB', 'CD200']",0.9995105235655231,0,0,19
314,Integrin-mediated Cell Adhesion WP185,0.7164317372273024,0.8848650918171171,0.2950780051355216,"['VAV3', 'ROCK2', 'PXN', 'ILK', 'BRAF', 'ITGAE', 'CDC42', 'MAPK10', 'RAP1A', 'ITGA10', 'AKT3', 'CAPN5', 'RAC3', 'GRB2', 'RAC1', 'MAPK6', 'CRK', 'VCL']",0.9995105235655231,0,0,18
315,Autophagy WP4923,0.722018484347709,0.8338415962359501,0.2715859925571343,"['BECN1', 'PRKAB2', 'ATG16L1', 'ATG9A', 'PRKAG1', 'WIPI2']",0.9995105235655231,0,0,6
316,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.722018484347709,0.8338415962359501,0.2715859925571343,"['NFKBIA', 'HDAC5', 'PPP3CA', 'SUPT4H1', 'SUPT5H', 'NFKB1']",0.9995105235655231,0,0,6
317,Endometrial cancer WP4155,0.7240627799158119,0.8654857525339453,0.2794455971738387,"['ILK', 'BRAF', 'FOS', 'FGF1', 'CASP9', 'CCND1', 'PIK3CA', 'CDH1', 'AKT3', 'GRB2', 'FGFR2', 'MAPK3', 'FGFR1']",0.9995105235655231,0,0,13
318,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.7274113893341212,0.8459969661216923,0.2692496076865545,"['MECP2', 'BECN1', 'MAP1LC3A', 'ATG16L1', 'WIPI1', 'WIPI2', 'PLA2G6', 'WDR45', 'GTPBP2']",0.9995105235655231,0,0,9
319,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.7285270830011759,0.7992565055762082,0.2531488947731819,"['JAG1', 'VHL']",0.9995105235655231,0,0,2
320,Cancer immunotherapy by CTLA4 blockade WP4582,0.7285270830011759,0.7992565055762082,0.2531488947731819,"['PIK3CA', 'PTPN11']",0.9995105235655231,0,0,2
321,Dopamine metabolism WP2436,0.7285270830011759,0.7992565055762082,0.2531488947731819,"['PPP2CB', 'PRKACA']",0.9995105235655231,0,0,2
322,Osteopontin Signaling WP1434,0.7285270830011759,0.7992565055762082,0.2531488947731819,"['NFKB1', 'MAPK3']",0.9995105235655231,0,0,2
323,Transcriptional cascade regulating adipogenesis WP4211,0.7285270830011759,0.7992565055762082,0.2531488947731819,"['CEBPD', 'PPARG']",0.9995105235655231,0,0,2
324,MAPK pathway in congenital thyroid cancer WP4928,0.7307585223617697,0.7991990846681922,0.25068654517388184,"['BRAF', 'FOS', 'MAPK3']",0.9995105235655231,0,0,3
325,Mitochondrial complex III assembly WP4921,0.7307585223617697,0.7991990846681922,0.25068654517388184,"['UQCC2', 'LYRM7', 'UQCRC2']",0.9995105235655231,0,0,3
326,SARS coronavirus and innate immunity WP4912,0.7307585223617697,0.7991990846681922,0.25068654517388184,"['STAT1', 'IRF9', 'IFNAR1']",0.9995105235655231,0,0,3
327,IL-5 signaling pathway WP127,0.7332487084847039,0.828634763056298,0.2571007834408671,"['GSK3A', 'STAT1', 'PTPN11', 'GRB2', 'FOS', 'MAPT', 'MAPK3']",0.9995105235655231,0,0,7
328,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7373559788940124,0.7991416309012875,0.2434860624017492,"['CASP9', 'EI24', 'SHISA5', 'BBC3']",0.9995105235655231,0,0,4
329,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.7373559788940124,0.7991416309012875,0.2434860624017492,"['PARP1', 'MDH2', 'GOT2', 'ELAVL1']",0.9995105235655231,0,0,4
330,Urea cycle and associated pathways WP4595,0.7373559788940124,0.7991416309012875,0.2434860624017492,"['MDH2', 'GOT2', 'PYCR1', 'NOS1']",0.9995105235655231,0,0,4
331,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7385836500838647,0.8409889728620779,0.2548372465221909,"['VAV3', 'ERN1', 'CDKN1B', 'HSPA5', 'SERBP1', 'RNF7', 'SQSTM1', 'TNFRSF21', 'NFKB1', 'HSPD1']",0.9995105235655231,0,0,10
332,ACE Inhibitor Pathway WP554,0.7435482866292588,0.7993138936535163,0.23685394801931145,['ATP6AP2'],0.9995105235655231,0,0,1
333,Acetylcholine Synthesis WP528,0.7435482866292588,0.7993138936535163,0.23685394801931145,['PDHA1'],0.9995105235655231,0,0,1
334,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.7435482866292588,0.7993138936535163,0.23685394801931145,['PPARG'],0.9995105235655231,0,0,1
335,EV release from cardiac cells and their functional effects WP3297,0.7435482866292588,0.7993138936535163,0.23685394801931145,['ERBB4'],0.9995105235655231,0,0,1
336,FTO Obesity Variant Mechanism WP3407,0.7435482866292588,0.7993138936535163,0.23685394801931145,['ARID5B'],0.9995105235655231,0,0,1
337,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.7435482866292588,0.7993138936535163,0.23685394801931145,['ACOT2'],0.9995105235655231,0,0,1
338,SARS-CoV-2 and COVID-19 Pathway WP4846,0.7435482866292588,0.7993138936535163,0.23685394801931145,['CTSL'],0.9995105235655231,0,0,1
339,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.7435482866292588,0.7993138936535163,0.23685394801931145,['MAPK3'],0.9995105235655231,0,0,1
340,Tgif disruption of Shh signaling WP3674,0.7435482866292588,0.7993138936535163,0.23685394801931145,['GLI3'],0.9995105235655231,0,0,1
341,Vitamin D Metabolism WP1531,0.7435482866292588,0.7993138936535163,0.23685394801931145,['RXRB'],0.9995105235655231,0,0,1
342,Nuclear Receptors Meta-Pathway WP2882,0.7442551100224609,0.906701276041946,0.2678136371705996,"['CDKN1B', 'HSP90AB1', 'MGST3', 'KEAP1', 'SLC2A3', 'TXN', 'SLC6A1', 'SLC5A3', 'SULT1A1', 'FGD4', 'RGS2', 'CCND1', 'SLC39A9', 'FTH1', 'PDE4B', 'ME1', 'SLC39A7', 'JUNB', 'SLC39A1', 'NCOA1', 'EGR1', 'GSTM3', 'NCOA2', 'ABCG8', 'ABCC4', 'HSP90AA1', 'PLK2', 'NCOA3', 'SLC2A13', 'PTGES3', 'TXNRD1', 'AIP', 'APOA1', 'SMARCA1', 'CES4A', 'TGFBR3', 'PSMC5', 'DNAJC7', 'NAV3', 'ACOX1', 'CDC37', 'BLVRB', 'SQSTM1', 'CES2', 'SLC27A5', 'BIRC2']",0.9995105235655231,0,0,46
343,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7465500921885178,0.8477466718184692,0.24779004622876788,"['WNT10B', 'CSNK2A1', 'CTNNBIP1', 'CSNK1E', 'SENP2', 'ELAVL1', 'NKD1', 'SFRP1', 'FRAT2', 'CCND2', 'CCND1', 'CSNK2B', 'ROR1']",0.9995105235655231,0,0,13
344,Regulation of Actin Cytoskeleton WP51,0.7523187858773142,0.8800138719082103,0.2504476600509474,"['CYFIP2', 'CHRM1', 'ROCK2', 'PXN', 'PDGFA', 'BRK1', 'FGF1', 'ACTG1', 'CDC42', 'RAC3', 'RAC1', 'MAPK6', 'FGF22', 'MAPK3', 'BRAF', 'ARPC5', 'SSH2', 'RHOA', 'DIAPH3', 'MRAS', 'PIK3CA', 'FGF12', 'CRK', 'VCL', 'FGFR2', 'FGFR1', 'ARHGEF6']",0.9995105235655231,0,0,27
345,Lung fibrosis WP3624,0.753689949713138,0.7990266246779273,0.22594411682532256,"['MECP2', 'FAM13A', 'PDGFA', 'ATP11A', 'IGF1', 'FGF1']",0.9995105235655231,0,0,6
346,Circadian rhythm related genes WP3594,0.758706077233424,0.885618759910196,0.24455549642203853,"['DDX5', 'CHRM1', 'PRKDC', 'ROCK2', 'BHLHE41', 'HEBP1', 'DBP', 'UBC', 'PRKG2', 'SKP1', 'EGR1', 'PRMT5', 'NCOA2', 'EGR3', 'KCND2', 'USP2', 'DYRK1A', 'CSNK1E', 'PML', 'NR2F6', 'SETX', 'MAPK10', 'STAR', 'MYBBP1A', 'PSPC1', 'THRAP3', 'ID2', 'CRY2', 'KLF9', 'CRY1', 'PPARG', 'ATF5', 'ATF4']",0.9995105235655231,0,0,33
347,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7620242047959659,0.7989690721649485,0.21714138474877004,"['MAP1LC3A', 'EIF2B2', 'ILK', 'RICTOR', 'IGF1', 'NFKB1', 'IGF1R']",0.9995105235655231,0,0,7
348,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7620242047959659,0.7989690721649485,0.21714138474877004,"['CASP9', 'DFFA', 'PARP1', 'PRKDC', 'CFLAR', 'SPTAN1', 'ACTG1']",0.9995105235655231,0,0,7
349,Netrin-UNC5B signaling pathway WP4747,0.7620242047959659,0.7989690721649485,0.21714138474877004,"['ARHGEF12', 'PIK3CA', 'NTN4', 'PTPN11', 'RAC1', 'RHOA', 'MAPK3']",0.9995105235655231,0,0,7
350,Senescence and Autophagy in Cancer WP615,0.7644462686511054,0.8485963526708789,0.22793598357519926,"['BECN1', 'SPARC', 'CDKN1B', 'PCNA', 'IGFBP3', 'BRAF', 'IGF1', 'CXCL14', 'IGF1R', 'RSL1D1', 'BMP2', 'ING2', 'MAP1LC3A', 'ATG16L1', 'CREG1', 'SLC39A1', 'SQSTM1']",0.9995105235655231,0,0,17
351,Insulin Signaling WP481,0.7645618625347199,0.8809762986980695,0.2365001470553334,"['ARF1', 'GSK3A', 'STXBP3', 'STXBP4', 'STXBP1', 'CBLB', 'PRKCZ', 'IGF1R', 'GYS2', 'RPS6KA6', 'EIF4EBP1', 'RAC1', 'MAP2K7', 'MAP4K5', 'MAPK6', 'MAP4K3', 'MAPK3', 'CAP1', 'EGR1', 'GAB1', 'PTPN11', 'FOS', 'MAPK10', 'TBC1D4', 'PIK3CA', 'TRIB3', 'GRB2', 'SGK3', 'MAP3K13', 'SGK2', 'CRK', 'PFKM']",0.9995105235655231,0,0,32
352,Breast cancer pathway WP4262,0.7661534546640721,0.8679382243247978,0.23119513230276434,"['MRE11', 'CETN3', 'FGF1', 'DLL1', 'IGF1R', 'DLL3', 'FRAT2', 'CCND1', 'AKT3', 'FGF22', 'SKP1', 'MAPK3', 'NCOA1', 'WNT10B', 'CSNK2A1', 'PARP1', 'NCOA3', 'BRAF', 'IGF1', 'FOS', 'CDK6', 'PIK3CA', 'CSNK2B', 'GRB2', 'FGFR1']",0.9995105235655231,0,0,25
353,BMP Signaling Pathway in Eyelid Development WP3927,0.7720652595267836,0.7376562224960395,0.1908214847086905,"['SFRP1', 'FGFR2', 'MAPK3']",0.9995105235655231,0,0,3
354,Globo Sphingolipid Metabolism WP1424,0.7720652595267836,0.7376562224960395,0.1908214847086905,"['B3GALNT1', 'ST8SIA1', 'ST6GALNAC4']",0.9995105235655231,0,0,3
355,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.7720652595267836,0.7376562224960395,0.1908214847086905,"['SETX', 'RBBP4', 'THRAP3']",0.9995105235655231,0,0,3
356,Angiogenesis WP1539,0.7733360629849529,0.7520659766052343,0.1933122218326061,"['FLT1', 'PIK3CA', 'TIMP2', 'FGFR2']",0.9995105235655231,0,0,4
357,IL-7 signaling pathway WP205,0.7733360629849529,0.7520659766052343,0.1933122218326061,"['CDKN1B', 'CCND1', 'STAT1', 'MAPK3']",0.9995105235655231,0,0,4
358,Microglia Pathogen Phagocytosis Pathway WP3937,0.7733360629849529,0.7520659766052343,0.1933122218326061,"['VAV3', 'PIK3CA', 'RAC3', 'RAC1']",0.9995105235655231,0,0,4
359,NRF2-ARE regulation WP4357,0.7733360629849529,0.7520659766052343,0.1933122218326061,"['AIMP2', 'PIK3CA', 'KEAP1', 'RBX1']",0.9995105235655231,0,0,4
360,PKC-gamma calcium signaling pathway in ataxia WP4760,0.7733360629849529,0.7520659766052343,0.1933122218326061,"['ITPR1', 'CA8', 'PLCB1', 'GRIA4']",0.9995105235655231,0,0,4
361,Glioblastoma signaling pathways WP2261,0.7742207367231633,0.8379435478177377,0.21442829292059856,"['CDKN1B', 'GAB1', 'BRAF', 'PRKCZ', 'IGF1R', 'CCND2', 'CDK6', 'CCND1', 'PIK3CA', 'AKT3', 'NF1', 'GRB2', 'MAP2K7', 'FGFR2', 'MAPK3', 'FGFR1']",0.9995105235655231,0,0,16
362,Prolactin Signaling Pathway WP2037,0.7763635148523355,0.828290557415378,0.20966885109460529,"['STAT1', 'PXN', 'PTPN11', 'FOS', 'NFKB1', 'NFKBIA', 'PIK3CA', 'EIF4EBP1', 'GRB2', 'RAC1', 'PPIB', 'CTSD', 'MAPK3', 'NFKBIB']",0.9995105235655231,0,0,14
363,Alanine and aspartate metabolism WP106,0.777561374160139,0.7103866806469037,0.1787281031825928,"['DARS', 'GOT2']",0.9995105235655231,0,0,2
364,Development and heterogeneity of the ILC family WP3893,0.777561374160139,0.7103866806469037,0.1787281031825928,"['ID2', 'TOX']",0.9995105235655231,0,0,2
365,Disorders of Folate Metabolism and Transport WP4259,0.777561374160139,0.7103866806469037,0.1787281031825928,"['ATIC', 'MTHFD1']",0.9995105235655231,0,0,2
366,Glycolysis in senescence WP5049,0.777561374160139,0.7103866806469037,0.1787281031825928,"['PGK1', 'GAPDH']",0.9995105235655231,0,0,2
367,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.777561374160139,0.7103866806469037,0.1787281031825928,"['NFKBIA', 'NFKB1']",0.9995105235655231,0,0,2
368,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.777561374160139,0.7103866806469037,0.1787281031825928,"['NFKB1', 'SOX4']",0.9995105235655231,0,0,2
369,Neuroinflammation WP4919,0.777561374160139,0.7103866806469037,0.1787281031825928,"['NFKBIA', 'FOS']",0.9995105235655231,0,0,2
370,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.777561374160139,0.7103866806469037,0.1787281031825928,"['ADAR', 'SAMHD1']",0.9995105235655231,0,0,2
371,AMP-activated protein kinase (AMPK) signaling WP1403,0.7799328376399065,0.8157472435611908,0.20275191240102308,"['GYS2', 'PRKAB2', 'PIK3CA', 'PRKAG1', 'LEPR', 'EIF4EBP1', 'PLCB1', 'ADIPOR1', 'EEF2', 'ELAVL1', 'ACACB', 'CAMKK2']",0.9995105235655231,0,0,12
372,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.7799328376399065,0.8157472435611908,0.20275191240102308,"['SCARB2', 'CDKN1B', 'PCNA', 'JAG1', 'YWHAQ', 'CDH2', 'MME', 'CTSL', 'DAG1', 'FAT1', 'ILK', 'VCL']",0.9995105235655231,0,0,12
373,BDNF-TrkB Signaling WP3676,0.7826383151753212,0.7669968508445463,0.18797912527285954,"['NTRK2', 'ARC', 'EIF4EBP1', 'GAB1', 'BRAF', 'GRB2']",0.9995105235655231,0,0,6
374,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7826383151753212,0.7669968508445463,0.18797912527285954,"['PDHA1', 'SLC16A1', 'IGFBP3', 'PGK1', 'SLC2A3', 'HIF1AN']",0.9995105235655231,0,0,6
375,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.7856038081521771,0.7987962166809974,0.1927516634731248,"['NFKBIA', 'MAPK10', 'OTUD5', 'NLRX1', 'TKFC', 'TRIM25', 'TRAF2', 'ISG15', 'NFKB1', 'NFKBIB']",0.9995105235655231,0,0,10
376,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.7883979600492984,0.8516450839328538,0.20248056996309532,"['WNT10B', 'SPARC', 'JAG1', 'PDCD6', 'EIF5A2', 'WNT8A', 'DLL1', 'DLL3', 'TJP1', 'FMNL2', 'CDH2', 'COL4A2', 'PIK3CA', 'RBBP4', 'CDH1', 'COL4A1', 'CTDSP1', 'ID2', 'AKT3', 'CLDN12', 'STRAP', 'GRB2', 'MEF2D', 'MAPK3']",0.9995105235655231,0,0,24
377,Small cell lung cancer WP4658,0.7901540807793102,0.8332688008193547,0.19625756214496357,"['CDKN1B', 'TRAF2', 'LAMC1', 'NFKB1', 'CKS1B', 'CASP9', 'RXRB', 'NFKBIA', 'CDK6', 'CCND1', 'CCNE2', 'PIK3CA', 'COL4A2', 'COL4A1', 'AKT3', 'BIRC2', 'SKP1', 'NFKBIB']",0.9995105235655231,0,0,18
378,Modulators of TCR signaling and T cell activation WP5072,0.800640897610166,0.7771935259041276,0.17280334585383816,"['NFKBIA', 'FIBP', 'CDKN1B', 'DGKA', 'CBLB', 'GRB2', 'RNF7', 'MEF2D', 'NFKB1']",0.9995105235655231,0,0,9
379,Benzo(a)pyrene metabolism WP696,0.8046653140778841,0.6393939393939394,0.13895874757914728,['AKR1A1'],0.9995105235655231,0,0,1
380,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.8046653140778841,0.6393939393939394,0.13895874757914728,['STAR'],0.9995105235655231,0,0,1
381,Drug Induction of Bile Acid Pathway WP2289,0.8046653140778841,0.6393939393939394,0.13895874757914728,['ABCC4'],0.9995105235655231,0,0,1
382,exRNA mechanism of action and biogenesis WP2805,0.8046653140778841,0.6393939393939394,0.13895874757914728,['XPO5'],0.9995105235655231,0,0,1
383,Fluoroacetic acid toxicity WP4966,0.8046653140778841,0.6393939393939394,0.13895874757914728,['ALDH3A2'],0.9995105235655231,0,0,1
384,Irinotecan pathway WP229,0.8046653140778841,0.6393939393939394,0.13895874757914728,['CES2'],0.9995105235655231,0,0,1
385,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.8046653140778841,0.6393939393939394,0.13895874757914728,['HIF1AN'],0.9995105235655231,0,0,1
386,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.8046653140778841,0.6393939393939394,0.13895874757914728,['CTDSP1'],0.9995105235655231,0,0,1
387,Small Ligand GPCRs WP247,0.8046653140778841,0.6393939393939394,0.13895874757914728,['LPAR1'],0.9995105235655231,0,0,1
388,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.8046653140778841,0.6393939393939394,0.13895874757914728,['IGF1R'],0.9995105235655231,0,0,1
389,Tamoxifen metabolism WP691,0.8046653140778841,0.6393939393939394,0.13895874757914728,['SULT1A1'],0.9995105235655231,0,0,1
390,EPO Receptor Signaling WP581,0.8053094915411252,0.7102209505642982,0.15378315799425513,"['STAT1', 'RASA1', 'GRB2', 'MAPK3']",0.9995105235655231,0,0,4
391,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8061977471819248,0.7263100379871988,0.1564662279703282,"['RAP1A', 'YWHAQ', 'RAC1', 'TEAD1', 'RHOA']",0.9995105235655231,0,0,5
392,Wnt signaling WP428,0.8063108097235091,0.8212910904091599,0.17681246613677376,"['WNT10B', 'CAMK2D', 'CSNK2A1', 'ROCK2', 'CTNNBIP1', 'CSNK1E', 'SENP2', 'RHOA', 'NKD1', 'PPP3CA', 'SFRP1', 'CCND2', 'FRAT2', 'CCND1', 'CSNK2B', 'ROR1', 'RAC1', 'PLCB1']",0.9995105235655231,0,0,18
393,Notch Signaling Pathway Netpath WP61,0.8066837415327534,0.7792434760117163,0.16739987440397516,"['NUMBL', 'JAG1', 'CCND1', 'PSEN2', 'CIR1', 'MAPT', 'DLL1', 'NFKB1', 'SKP1', 'DLL3']",0.9995105235655231,0,0,10
394,Apoptosis Modulation by HSP70 WP384,0.8080236720367481,0.6849051977770513,0.14599707939945125,"['CASP9', 'MAPK10', 'NFKB1']",0.9995105235655231,0,0,3
395,Ebstein-Barr virus LMP1 signaling WP262,0.8080236720367481,0.6849051977770513,0.14599707939945125,"['NFKBIA', 'HSP90AA1', 'NFKB1']",0.9995105235655231,0,0,3
396,Nicotine Activity on Dopaminergic Neurons WP1602,0.8080236720367481,0.6849051977770513,0.14599707939945125,"['CHRNA4', 'GNB1', 'PRKACA']",0.9995105235655231,0,0,3
397,Development of ureteric collection system WP5053,0.8089275381208456,0.7374309057675791,0.15636922637241088,"['GRIP1', 'CCND1', 'ILK', 'SLIT2', 'GLI3', 'FGFR2']",0.9995105235655231,0,0,6
398,MET in type 1 papillary renal cell carcinoma WP4205,0.812609004911488,0.7809187054026504,0.16204470299201126,"['CDC42', 'RAP1A', 'PIK3CA', 'AKT3', 'GAB1', 'PTPN11', 'BRAF', 'GRB2', 'RAC1', 'CRK', 'MAPK3']",0.9995105235655231,0,0,11
399,"GPCRs, Other WP117",0.8169243511994587,0.7517818929347735,0.15201690074985075,"['EDNRA', 'ADGRV1', 'CCKBR', 'GPR61', 'SSTR2', 'CELSR2', 'ADGRL2', 'ADGRL3']",0.9995105235655231,0,0,8
400,Dopaminergic Neurogenesis WP2855,0.8186467881605869,0.6392908207034601,0.1279237299612152,"['SOX2', 'ASCL1']",0.9995105235655231,0,0,2
401,FOXA2 pathway WP5066,0.8186467881605869,0.6392908207034601,0.1279237299612152,"['ABCC4', 'SLC27A5']",0.9995105235655231,0,0,2
402,Genes targeted by miRNAs in adipocytes WP1992,0.8186467881605869,0.6392908207034601,0.1279237299612152,"['IGF1', 'KCNJ2']",0.9995105235655231,0,0,2
403,Overview of nanoparticle effects WP3287,0.8186467881605869,0.6392908207034601,0.1279237299612152,"['COL4A1', 'AKT3']",0.9995105235655231,0,0,2
404,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.8214842761962402,0.7566732016287137,0.14879409646564798,"['NTRK2', 'PRKAB2', 'ARC', 'PIK3CA', 'AKT3', 'PRKAG1', 'EIF4EBP1', 'NF1', 'MAPK3']",0.9995105235655231,0,0,9
405,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8248816411442101,0.7984496124031008,0.15371382113636345,"['GAB1', 'PDGFA', 'BRAF', 'IGF1', 'IGF1R', 'MRAS', 'CCND1', 'PIK3CA', 'AKT3', 'PDGFC', 'EIF4EBP1', 'NF1', 'GRB2', 'EIF4E2', 'FGFR2', 'MAPK3']",0.9995105235655231,0,0,16
406,Selenium Micronutrient Network WP15,0.8261788483529416,0.7606218182314485,0.14523617662042587,"['PRDX4', 'SELENOS', 'FLAD1', 'TXNRD2', 'TXNRD1', 'PNPO', 'APOA1', 'TXN', 'KMO', 'NFKB1']",0.9995105235655231,0,0,10
407,Thermogenesis WP4321,0.8274218207561695,0.8089923371647509,0.1532560363184347,"['SMARCD1', 'PRKAB2', 'PRKAG1', 'ADCY3', 'SIRT6', 'ARID1A', 'ADCY8', 'ARID1B', 'ACTG1', 'CREB3', 'RPS6KA6', 'ZNF516', 'PRKG2', 'GRB2', 'PPARG', 'PRKACA', 'PRKG1', 'MGLL', 'FGFR1']",0.9995105235655231,0,0,19
408,Joubert Syndrome WP4656,0.8294255204685386,0.784484885096529,0.14671590225050637,"['MRE11', 'PARP1', 'CETN2', 'ARL3', 'RHOA', 'TMEM17', 'TCTN3', 'TMEM138', 'CSPP1', 'TCTN1', 'BBS9', 'CEP41', 'BBS4', 'ATF4']",0.9995105235655231,0,0,14
409,Peptide GPCRs WP24,0.8319781997314566,0.6946691222219457,0.12778371867141222,"['OPRD1', 'EDNRA', 'CCKBR', 'NMBR', 'SSTR2']",0.9995105235655231,0,0,5
410,Amyotrophic lateral sclerosis (ALS) WP2447,0.8326587562735752,0.7100550306963133,0.1300333555751456,"['CASP9', 'PPP3CA', 'CCS', 'TOMM40', 'NOS1', 'RAC1']",0.9995105235655231,0,0,6
411,Cannabinoid receptor signaling WP3869,0.8335082018846207,0.6727806641066185,0.1225212550551738,"['MAPK10', 'PRKAR1A', 'PRKACA', 'MAPK3']",0.9995105235655231,0,0,4
412,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8335082018846207,0.6727806641066185,0.1225212550551738,"['PIK3CA', 'CBLB', 'NFKB1', 'RHOA']",0.9995105235655231,0,0,4
413,Aryl Hydrocarbon Receptor Netpath WP2586,0.8346311042985036,0.7214554927391642,0.1304142217563215,"['HSP90AA1', 'CDKN1B', 'CDC37', 'AIP', 'NF1', 'NCOA7', 'NFKB1']",0.9995105235655231,0,0,7
414,Integrated Cancer Pathway WP1971,0.8346311042985036,0.7214554927391642,0.1304142217563215,"['CASP9', 'MRE11', 'CDKN1B', 'POU2F1', 'MSH2', 'STAT1', 'BBC3']",0.9995105235655231,0,0,7
415,Complement system WP2806,0.8373844250268025,0.7302369357940828,0.12959662755997972,"['FKBP2', 'SERPING1', 'APOA1', 'TXN', 'LAMC1', 'PRKACA', 'KLKB1', 'GNAI2']",0.9995105235655231,0,0,8
416,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.8390647330709022,0.6391876430205949,0.11215660691095766,"['ACOX1', 'ACOX3', 'PLA2G6']",0.9995105235655231,0,0,3
417,miRNAs involvement in the immune response in sepsis WP4329,0.8390647330709022,0.6391876430205949,0.11215660691095766,"['NFKBIA', 'TAB2', 'NFKB1']",0.9995105235655231,0,0,3
418,MAPK Signaling Pathway WP382,0.8394880867693871,0.8560516748438106,0.14977736356107185,"['RASGRF1', 'PDGFA', 'FGF1', 'DUSP16', 'CDC42', 'PPP3CA', 'RAP1A', 'STMN1', 'AKT3', 'RAC3', 'RAC1', 'PRKACA', 'MAP2K7', 'CACNG3', 'MAP4K3', 'FGF22', 'MAPK3', 'HSPA8', 'NTRK2', 'DUSP3', 'DUSP1', 'PLA2G4C', 'BRAF', 'TRAF2', 'FOS', 'HSPA2', 'NFKB1', 'MAPK10', 'NR4A1', 'MRAS', 'CACNB4', 'RASA1', 'NF1', 'RAPGEF2', 'GRB2', 'TAB2', 'MAPT', 'MAP3K13', 'FGF12', 'CRK', 'PTPN5', 'FGFR2', 'ATF4', 'FGFR1']",0.9995105235655231,0,0,44
419,Glucocorticoid Receptor Pathway WP2880,0.8406151604649298,0.7372052016751157,0.12799454117195377,"['TGFBR3', 'FGD4', 'RGS2', 'HSP90AA1', 'NAV3', 'PLK2', 'PTGES3', 'PDE4B', 'BIRC2']",0.9995105235655231,0,0,9
420,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8406151604649298,0.7372052016751157,0.12799454117195377,"['WNT10B', 'BMP2', 'FNTA', 'CEBPD', 'PPARG', 'LEMD3', 'JUNB', 'EMD', 'RUNX2']",0.9995105235655231,0,0,9
421,Wnt Signaling Pathway WP363,0.8406151604649298,0.7372052016751157,0.12799454117195377,"['BCL9', 'GSK3A', 'CDK6', 'CCND1', 'PPARG', 'ROR1', 'RAC1', 'CSNK1E', 'RHOA']",0.9995105235655231,0,0,9
422,Ectoderm Differentiation WP2858,0.8484978510168816,0.8068861518228607,0.13256149182747926,"['ABCC4', 'GRAMD1B', 'SMURF1', 'CTNND2', 'ARX', 'HMGB2', 'RRBP1', 'LDB2', 'PTPN13', 'CELSR2', 'GLI3', 'WDR44', 'SOX2', 'MECP2', 'PLCXD3', 'ARHGEF9', 'MAFB', 'ZNF219', 'ST8SIA4', 'UBTF', 'FGFR2', 'ANKS1B', 'LY6E']",0.9995105235655231,0,0,23
423,Glial Cell Differentiation WP2276,0.8512201341807821,0.5327806365542215,0.08582270607017242,['TPPP'],0.9995105235655231,0,0,1
424,Insulin signaling in adipocytes (diabetic condition) WP3635,0.8512201341807821,0.5327806365542215,0.08582270607017242,['TBC1D4'],0.9995105235655231,0,0,1
425,Insulin signaling in adipocytes (normal condition) WP3634,0.8512201341807821,0.5327806365542215,0.08582270607017242,['TBC1D4'],0.9995105235655231,0,0,1
426,Ketogenesis and Ketolysis WP4742,0.8512201341807821,0.5327806365542215,0.08582270607017242,['SLC16A1'],0.9995105235655231,0,0,1
427,Liver X receptor pathway WP2874,0.8512201341807821,0.5327806365542215,0.08582270607017242,['ABCG8'],0.9995105235655231,0,0,1
428,LTF danger signal response pathway WP4478,0.8512201341807821,0.5327806365542215,0.08582270607017242,['NFKB1'],0.9995105235655231,0,0,1
429,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.8512201341807821,0.5327806365542215,0.08582270607017242,['CDH1'],0.9995105235655231,0,0,1
430,Mevalonate pathway WP3963,0.8512201341807821,0.5327806365542215,0.08582270607017242,['PMVK'],0.9995105235655231,0,0,1
431,Role of Osx and miRNAs in tooth development WP3971,0.8512201341807821,0.5327806365542215,0.08582270607017242,['RUNX2'],0.9995105235655231,0,0,1
432,GPR40 Pathway WP3958,0.8527866700750446,0.5811214807497336,0.0925411879138044,"['PLCL1', 'PLCB1']",0.9995105235655231,0,0,2
433,Major receptors targeted by epinephrine and norepinephrine WP4589,0.8527866700750446,0.5811214807497336,0.0925411879138044,"['ADCY3', 'ADCY8']",0.9995105235655231,0,0,2
434,Tryptophan catabolism leading to NAD+ production WP4210,0.8527866700750446,0.5811214807497336,0.0925411879138044,"['QPRT', 'KMO']",0.9995105235655231,0,0,2
435,IL-4 signaling pathway WP395,0.8559969375327612,0.7098889207167638,0.11037954960279622,"['NFKBIA', 'PIK3CA', 'STAT1', 'PTPN11', 'GRB2', 'FOS', 'NFKB1', 'MAPK3']",0.9995105235655231,0,0,8
436,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8559969375327612,0.7098889207167638,0.11037954960279622,"['TGFBR3', 'STAT1', 'FOS', 'RUNX2', 'NFKB1', 'ENG', 'MAPK3', 'FBN1']",0.9995105235655231,0,0,8
437,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.8582077356456776,0.6390844062947068,0.09772181670121423,"['BMP2', 'THRA', 'STAT1', 'MAPK3']",0.9995105235655231,0,0,4
438,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.8656632959852841,0.5991847826086957,0.08643794719212233,"['H2AFY', 'H2AFJ', 'MAPK3']",0.9995105235655231,0,0,3
439,NAD+ biosynthetic pathways WP3645,0.8656632959852841,0.5991847826086957,0.08643794719212233,"['PARP1', 'QPRT', 'SIRT6']",0.9995105235655231,0,0,3
440,Ovarian infertility WP34,0.8656632959852841,0.5991847826086957,0.08643794719212233,"['EGR1', 'CDKN1B', 'CCND2']",0.9995105235655231,0,0,3
441,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8656632959852841,0.5991847826086957,0.08643794719212233,"['ABCC4', 'KEAP1', 'FOS']",0.9995105235655231,0,0,3
442,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8656632959852841,0.5991847826086957,0.08643794719212233,"['RASGRF1', 'ITPR1', 'MAPK3']",0.9995105235655231,0,0,3
443,IL-3 signaling pathway WP286,0.8723998420838939,0.6776094276094277,0.09249871857139622,"['YWHAQ', 'YWHAB', 'PTPN11', 'GRB2', 'FOS', 'PRKACA', 'MAPK3']",0.9995105235655231,0,0,7
444,TGF-beta Receptor Signaling WP560,0.8723998420838939,0.6776094276094277,0.09249871857139622,"['TGFBR3', 'STAT1', 'FOS', 'RUNX2', 'NFKB1', 'ENG', 'MAPK3']",0.9995105235655231,0,0,7
445,Kit receptor signaling pathway WP304,0.874012738085913,0.7011181773708854,0.09441280440726343,"['STAT1', 'MITF', 'PTPN11', 'GRB2', 'FOS', 'MAPT', 'JUNB', 'CRK', 'MAPK3']",0.9995105235655231,0,0,9
446,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8751256837851187,0.6389811104751002,0.08523226177409386,"['STAR', 'PIK3CA', 'PLCB1', 'NFKB1', 'MAPK3']",0.9995105235655231,0,0,5
447,B Cell Receptor Signaling Pathway WP23,0.8755578253421786,0.7483316590126292,0.09944884816299236,"['KLF11', 'GSK3A', 'CD81', 'GAB1', 'BRAF', 'PTPN11', 'ILF2', 'NFKB1', 'NFKBIA', 'CDC42', 'BLNK', 'GRB2', 'RAC1', 'CRK', 'MEF2D']",0.9995105235655231,0,0,15
448,AGE/RAGE pathway WP2324,0.8756579038295258,0.7097226202987166,0.09423681697646256,"['CASP9', 'CDC42', 'NFKBIA', 'STAT1', 'RAC1', 'PRKCZ', 'DDOST', 'RHOA', 'NFKB1', 'MAPK3']",0.9995105235655231,0,0,10
449,Cell cycle WP179,0.8772828505259133,0.7677542557835006,0.10051885400325163,"['YWHAE', 'CDKN2D', 'CDKN1B', 'PCNA', 'PRKDC', 'YWHAB', 'RBX1', 'STAG1', 'CCND2', 'ORC6', 'CDK6', 'CCND1', 'CCNE2', 'YWHAQ', 'ORC3', 'MCM4', 'MCM6', 'SKP1', 'YWHAH']",0.9995105235655231,0,0,19
450,Signal transduction through IL1R WP4496,0.8797074691839303,0.6085973158934532,0.07800139117696017,"['NFKBIA', 'TOLLIP', 'IL1RAP', 'NFKB1']",0.9995105235655231,0,0,4
451,Focal Adhesion WP306,0.8805355989304623,0.8098761596164943,0.10303643083588605,"['FLT1', 'ROCK2', 'PXN', 'RASGRF1', 'PDGFA', 'ILK', 'LAMC1', 'ACTG1', 'IGF1R', 'CDC42', 'RELN', 'CCND2', 'RAP1A', 'CCND1', 'AKT3', 'PDGFC', 'RAC3', 'RAC1', 'MAPK3', 'VAV3', 'BRAF', 'PARVB', 'IGF1', 'RHOA', 'MAPK10', 'COL4A2', 'PIK3CA', 'COL4A1', 'ITGA10', 'GRB2', 'CRK', 'VCL', 'BIRC2']",0.9995105235655231,0,0,33
452,Differentiation of white and brown adipocyte WP2895,0.8809575625501889,0.5326470307882948,0.06751078673463774,"['BMP2', 'PPARG']",0.9995105235655231,0,0,2
453,ERK Pathway in Huntington's Disease WP3853,0.8809575625501889,0.5326470307882948,0.06751078673463774,"['NTRK2', 'MAP2K7']",0.9995105235655231,0,0,2
454,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.8809575625501889,0.5326470307882948,0.06751078673463774,"['CD81', 'IGF1']",0.9995105235655231,0,0,2
455,Hypertrophy Model WP516,0.8809575625501889,0.5326470307882948,0.06751078673463774,"['WDR1', 'EIF4EBP1']",0.9995105235655231,0,0,2
456,TP53 network WP1742,0.8809575625501889,0.5326470307882948,0.06751078673463774,"['SUMO1', 'BBC3']",0.9995105235655231,0,0,2
457,Type II diabetes mellitus WP1584,0.8809575625501889,0.5326470307882948,0.06751078673463774,"['SURF1', 'PRKCZ']",0.9995105235655231,0,0,2
458,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.8866816877285211,0.4566282773829944,0.05491832902060225,['ADH5'],0.9995105235655231,0,0,1
459,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.8866816877285211,0.4566282773829944,0.05491832902060225,['CCND1'],0.9995105235655231,0,0,1
460,Nephrogenesis WP5052,0.8866816877285211,0.4566282773829944,0.05491832902060225,['JAG1'],0.9995105235655231,0,0,1
461,Selective expression of chemokine receptors during T-cell polarization WP4494,0.8866816877285211,0.4566282773829944,0.05491832902060225,['IFNGR2'],0.9995105235655231,0,0,1
462,Valproic acid pathway WP3871,0.8866816877285211,0.4566282773829944,0.05491832902060225,['HSD17B10'],0.9995105235655231,0,0,1
463,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.888305705839059,0.5638881410687845,0.06678653469605213,"['EIF4EBP1', 'PRKACA', 'MAPK3']",0.9995105235655231,0,0,3
464,Histone Modifications WP2369,0.8884302019363207,0.6576207802708712,0.07779600672724228,"['SETD5', 'SETD9', 'SMYD5', 'EHMT2', 'SMYD2', 'KMT5B', 'HIST1H4C']",0.9995105235655231,0,0,7
465,Folate Metabolism WP176,0.8898833552689743,0.638877755511022,0.07453460073235514,"['MTHFD1', 'FLAD1', 'MTHFD2', 'APOA1', 'NOS1', 'NFKB1']",0.9995105235655231,0,0,6
466,Notch Signaling WP268,0.8898833552689743,0.638877755511022,0.07453460073235514,"['NUMBL', 'JAG1', 'PSEN2', 'DTX4', 'DLL1', 'DLL3']",0.9995105235655231,0,0,6
467,T-cell receptor (TCR) signaling pathway WP69,0.8922701721979683,0.7095561291144887,0.08087968392504591,"['VAV3', 'CDC42', 'NFKBIA', 'CD83', 'ITPR1', 'CBLB', 'PTPN11', 'GRB2', 'FOS', 'CRK', 'NFKB1', 'MAPK3']",0.9995105235655231,0,0,12
468,MAPK Cascade WP422,0.8929116730018641,0.6143498745101492,0.06958594408440029,"['MAPK10', 'BRAF', 'GRB2', 'MAP2K7', 'MAPK3']",0.9995105235655231,0,0,5
469,Vitamin A and carotenoid metabolism WP716,0.8929116730018641,0.6143498745101492,0.06958594408440029,"['RXRB', 'SULT1A1', 'ABCG8', 'RBP4', 'CRABP1']",0.9995105235655231,0,0,5
470,Genes controlling nephrogenesis WP4823,0.8983152028827442,0.5808817791650409,0.06229043170400615,"['ILK', 'SLIT2', 'GLI3', 'FGFR2']",0.9995105235655231,0,0,4
471,Nanoparticle-mediated activation of receptor signaling WP2643,0.8983152028827442,0.5808817791650409,0.06229043170400615,"['MAPK10', 'PXN', 'AKT3', 'GRB2']",0.9995105235655231,0,0,4
472,White fat cell differentiation WP4149,0.8983152028827442,0.5808817791650409,0.06229043170400615,"['WNT10B', 'TLE3', 'CEBPD', 'PPARG']",0.9995105235655231,0,0,4
473,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9027313369476203,0.6387743413516609,0.0653659652520163,"['HSP90AA1', 'CCND1', 'TRAF2', 'FOS', 'CFLAR', 'MAP2K7', 'JUNB']",0.9995105235655231,0,0,7
474,Canonical and non-canonical TGF-B signaling WP3874,0.9040650360573234,0.49163018851323115,0.049582860529329684,"['BMP1', 'LOXL2']",0.9995105235655231,0,0,2
475,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.9040650360573234,0.49163018851323115,0.049582860529329684,"['ACOX1', 'ACOX3']",0.9995105235655231,0,0,2
476,Eicosanoid Synthesis WP167,0.9040650360573234,0.49163018851323115,0.049582860529329684,"['PTGES2', 'PLA2G6']",0.9995105235655231,0,0,2
477,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.9040650360573234,0.49163018851323115,0.049582860529329684,"['RHOA', 'FGFR2']",0.9995105235655231,0,0,2
478,PPAR-alpha pathway WP2878,0.9040650360573234,0.49163018851323115,0.049582860529329684,"['CCND1', 'APOA1']",0.9995105235655231,0,0,2
479,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9048311039253234,0.6182133852959375,0.061825652543640156,"['LARP1', 'STAT1', 'TRIM25', 'TRAF2', 'NFKB1', 'IFNAR1']",0.9995105235655231,0,0,6
480,TLR4 Signaling and Tolerance WP3851,0.9074672555134319,0.5325133485888635,0.05170587226115812,"['NFKBIA', 'TAB2', 'NFKB1']",0.9995105235655231,0,0,3
481,ErbB signaling pathway WP673,0.9096766716672946,0.7192763240366691,0.06809104735273724,"['CAMK2D', 'CDKN1B', 'GAB1', 'CBLB', 'BRAF', 'MAPK10', 'CCND1', 'NRG3', 'PIK3CA', 'ERBB4', 'AKT3', 'EIF4EBP1', 'GRB2', 'MAP2K7', 'CRK', 'MAPK3']",0.9995105235655231,0,0,16
482,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9130469916946811,0.6651858221075762,0.060510577413277734,"['RYR2', 'CACNB4', 'CDH2', 'SGCB', 'ITGA10', 'DAG1', 'ATP2A2', 'EMD', 'CACNG3', 'ACTG1']",0.9995105235655231,0,0,10
483,15q11.2 copy number variation syndrome WP4940,0.9136927412486764,0.39951400800457404,0.036060507251979346,['TUBGCP2'],0.9995105235655231,0,0,1
484,Blood Clotting Cascade WP272,0.9136927412486764,0.39951400800457404,0.036060507251979346,['KLKB1'],0.9995105235655231,0,0,1
485,Cytokines and Inflammatory Response WP530,0.9136927412486764,0.39951400800457404,0.036060507251979346,['PDGFA'],0.9995105235655231,0,0,1
486,Estrogen Receptor Pathway WP2881,0.9136927412486764,0.39951400800457404,0.036060507251979346,['ACOX1'],0.9995105235655231,0,0,1
487,Farnesoid X receptor pathway WP2879,0.9136927412486764,0.39951400800457404,0.036060507251979346,['SLC27A5'],0.9995105235655231,0,0,1
488,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.9136927412486764,0.39951400800457404,0.036060507251979346,['APOA1'],0.9995105235655231,0,0,1
489,Trans-sulfuration pathway WP2333,0.9136927412486764,0.39951400800457404,0.036060507251979346,['MAT2B'],0.9995105235655231,0,0,1
490,Cardiac Progenitor Differentiation WP2406,0.9143355811592391,0.5555762891086645,0.049756089227704095,"['SOX2', 'BMP1', 'THY1', 'IGF1']",0.9995105235655231,0,0,4
491,Complement and Coagulation Cascades WP558,0.9143355811592391,0.5555762891086645,0.049756089227704095,"['CLTC', 'SERPING1', 'CLU', 'KLKB1']",0.9995105235655231,0,0,4
492,Oxidation by Cytochrome P450 WP43,0.9143355811592391,0.5555762891086645,0.049756089227704095,"['CYP4Z1', 'CYB5R1', 'CYB5R3', 'CYP20A1']",0.9995105235655231,0,0,4
493,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9154376459165707,0.6209749268168512,0.054865014169961604,"['ADCY3', 'GRB2', 'ADCY8', 'LEMD3', 'EMD', 'RHOA', 'MAPK3']",0.9995105235655231,0,0,7
494,Allograft Rejection WP2328,0.9179935654607351,0.5988405382192957,0.05123972938430663,"['CASP9', 'STAT1', 'HLA-C', 'HLA-A', 'HLA-F', 'PRKCZ']",0.9995105235655231,0,0,6
495,22q11.2 copy number variation syndrome WP4657,0.9184378499038647,0.7092225731329952,0.06034139510061744,"['CBX5', 'TXNRD2', 'EMC10', 'RBX1', 'CDC42', 'XPO1', 'HIRIP3', 'RELN', 'POLR2A', 'THAP7', 'HIST1H4C', 'KPNB1', 'FGFR2', 'RAN', 'FGFR1', 'DGCR2']",0.9995105235655231,0,0,16
496,Type 2 papillary renal cell carcinoma WP4241,0.9220008997178987,0.5703655245727369,0.0463188592822204,"['EGLN2', 'CUL2', 'ELOC', 'VHL', 'RBX1']",0.9995105235655231,0,0,5
497,Glycosaminoglycan degradation WP4815,0.9229220770739641,0.45647289513460515,0.03661390618298903,"['HPSE2', 'HEXB']",0.9995105235655231,0,0,2
498,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9229220770739641,0.45647289513460515,0.03661390618298903,"['ACADL', 'ACADS']",0.9995105235655231,0,0,2
499,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.9229220770739641,0.45647289513460515,0.03661390618298903,"['BMP2', 'CDC37']",0.9995105235655231,0,0,2
500,Transcription factor regulation in adipogenesis WP3599,0.9229220770739641,0.45647289513460515,0.03661390618298903,"['CEBPD', 'PPARG']",0.9995105235655231,0,0,2
501,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9235973720915218,0.5044411658436709,0.04009250302509357,"['BCL9', 'CCND1', 'PML']",0.9995105235655231,0,0,3
502,Pathways in clear cell renal cell carcinoma WP4018,0.9238534379560506,0.680243221128072,0.05387651261955284,"['FLT1', 'BHLHE41', 'PLOD2', 'ENO2', 'ACACB', 'ME1', 'PGK1', 'VHL', 'ALDOA', 'GAPDH', 'SQSTM1', 'PFKM', 'KCNJ2']",0.9995105235655231,0,0,13
503,Hippo-Merlin Signaling Dysregulation WP4541,0.9264795447100289,0.6994442674595589,0.053411880490557,"['NTRK2', 'FLT1', 'ITGAE', 'IGF1R', 'RBX1', 'DDB1', 'CCND1', 'CDH2', 'CDH1', 'PRKAR1A', 'ITGA10', 'PRKACA', 'TEAD1', 'FGFR2', 'CDH18', 'FGFR1']",0.9995105235655231,0,0,16
504,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.9280617631680388,0.5323795898903195,0.03974585946094232,"['CDKN1B', 'PIK3CA', 'EIF4EBP1', 'RICTOR']",0.9995105235655231,0,0,4
505,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9280617631680388,0.5323795898903195,0.03974585946094232,"['CASP9', 'PIK3CA', 'BRAF', 'NOS1']",0.9995105235655231,0,0,4
506,Zinc homeostasis WP3529,0.9280617631680388,0.5323795898903195,0.03974585946094232,"['SLC30A9', 'SLC39A9', 'SLC39A7', 'SLC39A1']",0.9995105235655231,0,0,4
507,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9322927889545095,0.6384637431928919,0.04476164748253937,"['GHR', 'PTPRD', 'MAPK10', 'CNTFR', 'IFNGR2', 'STMN1', 'RICTOR', 'MAPK6', 'IFNAR1', 'MAPK3']",0.9995105235655231,0,0,10
508,Wnt signaling pathway and pluripotency WP399,0.9324947956744336,0.6769618712229903,0.04731402178668157,"['WNT10B', 'CSNK1E', 'PRKCZ', 'FBXW2', 'RHOA', 'NKD1', 'SOX2', 'MAPK10', 'PPP2CB', 'CCND2', 'CCND1', 'PPP2R2B', 'PRKD1', 'PAFAH1B1']",0.9995105235655231,0,0,14
509,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.9337318969772911,0.5506484021870004,0.03775571988910739,"['MAPK10', 'FOS', 'MAP2K7', 'JUNB', 'MAPK3']",0.9995105235655231,0,0,5
510,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.934266608626349,0.3550917984880249,0.024143910507989717,['PMVK'],0.9995105235655231,0,0,1
511,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.934266608626349,0.3550917984880249,0.024143910507989717,['MAPK3'],0.9995105235655231,0,0,1
512,Nanoparticle triggered regulated necrosis WP2513,0.934266608626349,0.3550917984880249,0.024143910507989717,['PARP1'],0.9995105235655231,0,0,1
513,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9345046198137105,0.6081488453301688,0.041195217344968206,"['RXRB', 'CAMK2D', 'STAT1', 'ISG15', 'PLCB1', 'PRKCZ', 'NFKB1', 'MAPK3']",0.9995105235655231,0,0,8
514,Copper homeostasis WP3286,0.9365990365156297,0.5881865316211491,0.038526224254441625,"['BACE1', 'CCS', 'CCND1', 'SCO1', 'PIK3CA', 'COX11', 'MAPT']",0.9995105235655231,0,0,7
515,MTHFR deficiency WP4288,0.9371106918762382,0.4791762013729977,0.03112434839465293,"['CASP9', 'EHMT2', 'HNMT']",0.9995105235655231,0,0,3
516,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.9382417959841908,0.42600324087312935,0.02715667779090929,"['EIF4EBP1', 'MAPK3']",0.9995105235655231,0,0,2
517,Imatinib and Chronic Myeloid Leukemia WP3640,0.9382417959841908,0.42600324087312935,0.02715667779090929,"['CDKN1B', 'FLT1']",0.9995105235655231,0,0,2
518,Nanomaterial induced apoptosis WP2507,0.9382417959841908,0.42600324087312935,0.02715667779090929,"['CASP9', 'CFLAR']",0.9995105235655231,0,0,2
519,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.9382417959841908,0.42600324087312935,0.02715667779090929,"['GSK3A', 'BCL2L2']",0.9995105235655231,0,0,2
520,Differentiation Pathway WP2848,0.9397697688942509,0.5110386266094421,0.03174590367647208,"['NT5E', 'PDGFA', 'IGF1', 'FGF1']",0.9995105235655231,0,0,4
521,Hepatitis B infection WP4666,0.9444691582995862,0.7050422202717835,0.04028064597152437,"['EGR3', 'PCNA', 'ATP6AP1', 'YWHAB', 'STAT1', 'BRAF', 'FOS', 'NFKB1', 'CASP9', 'DDB1', 'MAPK10', 'CREB3', 'YWHAQ', 'PIK3CA', 'AKT3', 'GRB2', 'TAB2', 'MAP2K7', 'IFNAR1', 'ATF4', 'MAPK3']",0.9995105235655231,0,0,21
522,Vitamin B12 metabolism WP1533,0.9483824882275149,0.45631742399476954,0.02418363225703002,"['MMAB', 'APOA1', 'NFKB1']",0.9995105235655231,0,0,3
523,Glutathione metabolism WP100,0.9499370408368242,0.31955403087478557,0.016412157421619562,['GSS'],0.9995105235655231,0,0,1
524,Inflammatory Response Pathway WP453,0.9499370408368242,0.31955403087478557,0.016412157421619562,['LAMC1'],0.9995105235655231,0,0,1
525,Leptin Insulin Overlap WP3935,0.9499370408368242,0.31955403087478557,0.016412157421619562,['LEPR'],0.9995105235655231,0,0,1
526,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.9499370408368242,0.31955403087478557,0.016412157421619562,['STAG1'],0.9995105235655231,0,0,1
527,Purinergic signaling WP4900,0.9506388623129816,0.399342293394338,0.020215119715761395,"['GNAO1', 'GNAI2']",0.9995105235655231,0,0,2
528,Ferroptosis WP4313,0.9525621569948021,0.5150303746514763,0.025030433678372637,"['MAP1LC3A', 'FTH1', 'GSS', 'LPCAT3', 'SLC3A2']",0.9995105235655231,0,0,5
529,DNA damage response (only ATM dependent) WP710,0.9573353999916339,0.6466239488627549,0.028193760345423813,"['WNT10B', 'CDKN1B', 'NFKB1', 'RHOA', 'BBC3', 'CDC42', 'MAPK10', 'CCND2', 'CCND1', 'PIK3CA', 'CCNG2', 'AKT3', 'RAC3', 'GRB2', 'RAC1']",0.9995105235655231,0,0,15
530,Hematopoietic Stem Cell Differentiation WP2849,0.9577472103833945,0.4355367172872894,0.01880273335706943,"['ZNF835', 'FOSB', 'FOS']",0.9995105235655231,0,0,3
531,Wnt signaling in kidney disease WP4150,0.9577472103833945,0.4355367172872894,0.01880273335706943,"['MAPK10', 'WNT10B', 'RHOA']",0.9995105235655231,0,0,3
532,TGF-beta Signaling Pathway WP366,0.9584250950286485,0.6784781638157211,0.028810806964183668,"['KLF11', 'UBE2I', 'SMURF1', 'WWP1', 'FOS', 'RUNX2', 'RHOA', 'PML', 'RBX1', 'TGFBR3', 'CDC42', 'CCND1', 'SUMO1', 'SNIP1', 'STRAP', 'FOSB', 'GRB2', 'RAC1', 'JUNB', 'SKP1']",0.9995105235655231,0,0,20
533,Phosphodiesterases in neuronal function WP4222,0.9596017866983304,0.5450018159975414,0.022474177809731818,"['PDE10A', 'PDE1C', 'PDE4D', 'PDE4B', 'ADCY3', 'NOS1', 'ADCY8']",0.9995105235655231,0,0,7
534,Nephrotic syndrome WP4758,0.9600200939384924,0.4988909559244419,0.02035528159887953,"['SCARB2', 'YARS', 'ARHGDIA', 'TTC21B', 'WDR73']",0.9995105235655231,0,0,5
535,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.9606359232967321,0.3758179279718751,0.015092770464697723,"['CASP9', 'BBC3']",0.9995105235655231,0,0,2
536,Statin inhibition of cholesterol production WP430,0.9606359232967321,0.3758179279718751,0.015092770464697723,"['ABCG8', 'APOA1']",0.9995105235655231,0,0,2
537,Pathways affected in adenoid cystic carcinoma WP3651,0.9613623960971507,0.5744527220630372,0.02263564198652154,"['MAGI1', 'MORF4L1', 'PIK3CA', 'PRKDC', 'MAGI2', 'JMJD1C', 'ARID5B', 'ARID1A', 'DTX4']",0.9995105235655231,0,0,9
538,ID signaling pathway WP53,0.9618724309323646,0.29047767555486254,0.011291868028092804,['ID2'],0.9995105235655231,0,0,1
539,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.9618724309323646,0.29047767555486254,0.011291868028092804,['NFKB1'],0.9995105235655231,0,0,1
540,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.9618724309323646,0.29047767555486254,0.011291868028092804,['DKK3'],0.9995105235655231,0,0,1
541,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9631337964385271,0.5550670668675974,0.020849950775091858,"['ACTR2', 'CDKN1B', 'ROCK2', 'ERBB4', 'PFN4', 'GRB2', 'NOS1', 'RHOA']",0.9995105235655231,0,0,8
542,Fatty acid beta-oxidation WP143,0.9652253181516619,0.45616186388718577,0.016145262815061664,"['GCDH', 'ECHS1', 'ACADL', 'ACADS']",0.9995105235655231,0,0,4
543,Prostaglandin Synthesis and Regulation WP98,0.9652253181516619,0.45616186388718577,0.016145262815061664,"['ABCC4', 'EDNRA', 'MITF', 'PPARG']",0.9995105235655231,0,0,4
544,Glycerophospholipid Biosynthetic Pathway WP2533,0.9654991596578063,0.4165630285543727,0.014625547712582846,"['PGS1', 'PIK3CA', 'PTPMT1']",0.9995105235655231,0,0,3
545,ESC Pluripotency Pathways WP3931,0.9662695607844861,0.6294942292585655,0.02159947999128045,"['WNT10B', 'ACTR2', 'GAB1', 'PDGFA', 'BRAF', 'PTPN11', 'FOS', 'FGF1', 'AKT3', 'GRB2', 'MAPK6', 'FGF12', 'FGF22', 'FGFR2', 'FGFR1']",0.9995105235655231,0,0,15
546,Interleukin-11 Signaling Pathway WP2332,0.9663877106090765,0.48372968378692477,0.016538799423013777,"['STAT1', 'PTPN11', 'GRB2', 'RUNX2', 'MAPK3']",0.9995105235655231,0,0,5
547,Non-small cell lung cancer WP4255,0.9685368630442592,0.5849006116207951,0.018698532573676468,"['CASP9', 'RXRB', 'RASSF1', 'CDK6', 'CCND1', 'PIK3CA', 'AKT3', 'CRABP1', 'BRAF', 'GRB2', 'MAPK3']",0.9995105235655231,0,0,11
548,Omega-9 FA synthesis WP4724,0.9709628275918275,0.2662473794549266,0.00784553656491759,['ACOT2'],0.9995105235655231,0,0,1
549,Neovascularisation processes WP4331,0.9718945567680579,0.39917048054919907,0.01137953653074786,"['JAG1', 'NFKB1', 'MAPK3']",0.9995105235655231,0,0,3
550,Adipogenesis WP236,0.9732004237718582,0.6221718031133799,0.01690144176812862,"['NCOA1', 'GDF10', 'CNTFR', 'WNT10B', 'NCOA2', 'MBNL1', 'CEBPD', 'STAT1', 'IGF1', 'BSCL2', 'BMP2', 'BMP1', 'NDN', 'TRIB3', 'PPARG', 'MEF2D']",0.9995105235655231,0,0,16
551,MECP2 and Associated Rett Syndrome WP3584,0.9736082325720784,0.5597039316548752,0.014969998934655459,"['MECP2', 'PRPF38A', 'CEBPD', 'SST', 'NF1', 'TAP1', 'YBX1', 'IGF1', 'IGF1R', 'GRIA4']",0.9995105235655231,0,0,10
552,Heart Development WP1591,0.9751151546645785,0.3361979441024638,0.00847208989050822,"['BMP2', 'PTPN11']",0.9995105235655231,0,0,2
553,Toll-like Receptor Signaling related to MyD88 WP3858,0.9751151546645785,0.3361979441024638,0.00847208989050822,"['TOLLIP', 'NFKB1']",0.9995105235655231,0,0,2
554,Integrated breast cancer pathway WP1984,0.9759280450546362,0.6603090432204356,0.01608936722340325,"['GSK3A', 'MRE11', 'RALGAPA1', 'STAT1', 'ZMYND8', 'NCOA3', 'DCAKD', 'BRAF', 'NFKB1', 'PML', 'CASP9', 'CDC42', 'FER', 'RAP1A', 'CCND1', 'MSH2', 'CDH1', 'ZMIZ1', 'DAG1', 'NF1', 'RAC1', 'MAP3K13', 'RPP38']",0.9995105235655231,0,0,23
555,Bladder cancer WP2828,0.9761812702023032,0.4256747734859323,0.010261734165278508,"['RASSF1', 'CCND1', 'CDH1', 'BRAF']",0.9995105235655231,0,0,4
556,Vitamin D-sensitive calcium signaling in depression WP4698,0.9761812702023032,0.4256747734859323,0.010261734165278508,"['GRM5', 'CHRM1', 'ITPR1', 'ATP2B3']",0.9995105235655231,0,0,4
557,Fatty acid transporters WP5061,0.9778862302085596,0.24574482121651933,0.0054953321132094465,['FABP5'],0.9995105235655231,0,0,1
558,Kennedy pathway from sphingolipids WP3933,0.9778862302085596,0.24574482121651933,0.0054953321132094465,['SGPL1'],0.9995105235655231,0,0,1
559,Mammalian disorder of sexual development WP4842,0.9778862302085596,0.24574482121651933,0.0054953321132094465,['FGFR2'],0.9995105235655231,0,0,1
560,Riboflavin and CoQ disorders WP5037,0.9778862302085596,0.24574482121651933,0.0054953321132094465,['FLAD1'],0.9995105235655231,0,0,1
561,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9828094542790385,0.61784541402768,0.010713450997633748,"['CAP1', 'ABCG8', 'PRKAB2', 'GSK3A', 'THRA', 'PRKAG1', 'CBLB', 'MAPK10', 'RPS6KA6', 'PIK3CA', 'EIF4EBP1', 'RICTOR', 'MAP2K7', 'MAP3K13', 'MAP4K5', 'MAPK6', 'CRK', 'MAP4K3', 'MAPK3']",0.9995105235655231,0,0,19
562,Cholesterol Biosynthesis Pathway WP197,0.983159097272344,0.22817119986931308,0.0038753334105422034,['PMVK'],0.9995105235655231,0,0,1
563,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.983159097272344,0.22817119986931308,0.0038753334105422034,['PDHA1'],0.9995105235655231,0,0,1
564,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.9843769325428681,0.30412462382722605,0.0047888660764364085,"['CBX5', 'RBBP4']",0.9995105235655231,0,0,2
565,Sleep regulation WP3591,0.9843769325428681,0.30412462382722605,0.0047888660764364085,"['STAR', 'FOS']",0.9995105235655231,0,0,2
566,Cytoplasmic Ribosomal Proteins WP477,0.9849696520583668,0.5600859034593975,0.00848219205202807,"['RPL4', 'RPL5', 'RPS8', 'RPLP0', 'RPL22', 'MRPL19', 'RPS6KA6', 'RPS17', 'RPS29', 'RPL36', 'RPS3', 'RPL37', 'RPL28']",0.9995105235655231,0,0,13
567,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.9871748271611582,0.21294072803506767,0.002748665617070529,['SIRT6'],0.9995105235655231,0,0,1
568,Monoamine GPCRs WP58,0.9876491015304123,0.2902747809811007,0.0036074782911358063,"['CHRM1', 'HTR5A']",0.9995105235655231,0,0,2
569,Endoderm differentiation WP2853,0.9884525794733597,0.5824578631734326,0.006765020764457123,"['VAV3', 'STAT1', 'CTR9', 'WNT8A', 'RTF1', 'LAMC1', 'TRERF1', 'ELAVL1', 'SOX2', 'SFRP1', 'SESN1', 'UBR5', 'NABP2', 'LEO1', 'CEBPZ', 'ASCC3', 'TOX']",0.9995105235655231,0,0,17
570,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.99023307375167,0.1996140651801029,0.00195919918069215,['PPARG'],0.9995105235655231,0,0,1
571,Ethanol effects on histone modifications WP3996,0.9923116704244339,0.26603755600038126,0.0020532877397320486,"['HDAC5', 'EHMT2']",0.9995105235655231,0,0,2
572,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.9923116704244339,0.26603755600038126,0.0020532877397320486,"['TGFBR3', 'PROM1']",0.9995105235655231,0,0,2
573,One-carbon metabolism and related pathways WP3940,0.992709259494708,0.3545382292163408,0.0025943150009507653,"['DMGDH', 'GSS', 'BCAT1', 'CDO1']",0.9995105235655231,0,0,4
574,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.994335694872534,0.17740296042182835,0.0010077212205819156,['TERF2'],0.9995105235655231,0,0,1
575,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9951536430115822,0.33581808598750096,0.0016314508253595437,"['NR1H2', 'PMVK', 'ACOT2', 'TM7SF2']",0.9995105235655231,0,0,4
576,Mesodermal commitment pathway WP2857,0.9958350197628208,0.5192682074576948,0.002167258255262701,"['VAV3', 'ARID5B', 'TRERF1', 'DLL1', 'SOX2', 'CCND1', 'PRKAR1A', 'SESN1', 'UBR5', 'NABP2', 'ASCC3', 'PRKACA', 'TOX', 'TEAD1', 'FGFR1']",0.9995105235655231,0,0,15
577,Gastric Cancer Network 1 WP2361,0.9967148316337177,0.1596340766152087,0.0005252881218387289,['MCM4'],0.9995105235655231,0,0,1
578,Glycerolipids and Glycerophospholipids WP4722,0.9967148316337177,0.1596340766152087,0.0005252881218387289,['DGAT2'],0.9995105235655231,0,0,1
579,Phosphoinositides metabolism WP4971,0.9974016673554582,0.31116228758854114,0.0008095553326733021,"['PIK3CA', 'MTMR9', 'PLCB1', 'SBF2']",0.9995105235655231,0,0,4
580,"GPCRs, Class A Rhodopsin-like WP455",0.99885836535405,0.4135818323264583,0.0004724290707570303,"['OPRD1', 'GPR173', 'EDNRA', 'CHRM1', 'CCKBR', 'GPR22', 'PRLHR', 'NMBR', 'SSTR2', 'HTR5A']",0.9995105235655231,0,0,10
581,Male infertility WP4673,0.9988756766532776,0.4271299507719848,0.0004805023463859479,"['NANOS1', 'GNAO1', 'DDX4', 'MTHFD1', 'UBE2B', 'PARP1', 'XRCC5', 'MOV10L1', 'NOS1', 'CDC42BPA', 'CLU']",0.9995105235655231,0,0,11
582,ATM Signaling Pathway WP2516,0.9988917741174389,0.1993851873034029,0.00022108635461924193,"['NFKBIA', 'MRE11']",0.9995105235655231,0,0,2
583,TYROBP causal network in microglia WP3945,0.9995105235655231,0.11817334773309617,5.785722992934414e-05,['ABCC4'],0.9995105235655231,0,0,1
